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Preface    
Welcome the 2017 Severe Maternal Morbidity 
(SMM) Report from the National Perinatal
Epidemiology Centre (NPEC). 
This year 2019 marks a significant year for the 
NPEC as it celebrates 10 years of data collection 
and audit in the maternity services. The NPEC 
have always strategically aimed to close the 
audit loop and since the establishment of the 
National Women and Infants Health Programme 
(NWIHP) in January 2017 a number of the NPEC 
recommendations have been progressed. 
The ongoing interaction with the NWIHP in 
assessing our recommendations with a view 
to implementation supports the mission of 
improving maternity care in Ireland.
Studying SMM is required to assess the quality 
of care in our service. The incidence of maternal 
mortality is now low and there are thankfully 
fewer cases from which to learn. Examining 
SMM provides us with opportunities to look at 
the care provided to women who may indeed 
be very ill and allow us identify good practice 
and areas that could be improved. Tracking 
significant morbidities in a longitudinal 
manner can identify changes in practice and 
indeed changes in morbidities emanating from 
background change in the population or the 
way the service is provided. It is important 
that we always consider the data in the context 
of the individual woman’s experience. The 
significant trauma associated with SMM events 
during the experience of childbirth can have a 
profound psychological effect on a woman, her 
partner and their families.
As Director of the NPEC I am proud that the 
maternity services in Ireland, through the 
NPEC, are collecting data that can influence and 
improve patient care and I wish to acknowledge 
the effort and time spent participating in the 
NPEC audits. The input from our public/patient 
representatives brings great grounding to 
our endeavours and provides the audits with 
valuable insight.
This report adds to a body of evidence to allow 
us to make international comparisons and 
learn more about maternal morbidity in Ireland. 
Working and learning together we can ensure 
that all pregnant and recently pregnant women 
receive safe high quality care in appropriate 
settings. I commend that all healthcare 
professionals involved in the maternity service 
be aware of the findings in this report.
Richard A Greene, Director, NPEC
National Perinatal Epidemiology Centre
5th Floor, Cork University Maternity Hospital
Wilton, Cork, Ireland
Email: npec@ucc.ie
Tel: +353 (21) 420 5017
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Executive summary 
The sixth report from the National Clinical 
Audit of Severe Maternal Morbidity (SMM) 
in Ireland reports on 391 cases of SMM 
occurring in all 19 Irish maternity units in 
2017. 
The SMM rate is a composite rate of a group of 
clearly defined severe maternal morbidities. 
Almost three quarters of the women (n=291, 
74.4%) who experienced SMM in 2017 were 
diagnosed with one morbidity; 21% (n=81, 
20.7%) were diagnosed with two morbidities; 
3% (n=11, 2.8%) with three SMMs; and 2% 
(n=8, 2.0%) with four morbidities.
From 2012 to 2017, the SMM rate varied 
from 4.44 to 6.42 per 1,000 maternities 
or from one in 225 maternities to one in 
156 maternities. The SMM rate has shown 
a steady increase since the reference 
year of 2012 (SMM rate was 4.44 per 1000 
maternities), with the 2017 rate recording a 
value 45% higher than the reference year. 
Major obstetric haemorrhage (MOH) remains 
the most frequently reported SMM event 
in 2017, accounting for approximately half 
(48.8%) of SMM cases. The incidence of 
MOH cases increased from 2.34 per 1,000 
maternities in 2011 and 2.49 in 2012 to 3.14 
per 1,000 maternities in 2017. 
Admission to an intensive or coronary 
care unit (ICU/CCU) was the second most 
common event, having been reported in 
over a third (38.1%) of SMM cases. However, 
nearly half (46.7%) of the women admitted 
to an ICU/CCU in 2017 had not experienced 
a SMM as defined in this audit. This marks 
a sharp increase in the occurrence of this 
phenomenon (recording 34.4% in 2016). 
The next most common reported morbidities 
were renal or liver dysfunction (12.8%), 
peripartum hysterectomy (8.4%) and 
pulmonary embolism (6.4%). Septicaemic 
shock and pulmonary oedema were similar 
accounting for 3.3% of reported morbidities.
In 2017, the number and rate of cases for 
each specific morbidities, excluding MOH, 
renal or liver dysfunction, ICU/CCU admission 
and peripartum hysterectomy were broadly 
in line with those reported in 2012-2016. 
The rate of peripartum hysterectomy (PH) 
in 2017 (0.54 per 1,000 maternities) was 
almost double the rate for 2012-2015 
(p-value=0.02). Abnormal placentation, 
primarily morbidly adherent placenta, was 
the most commonly reported indication for 
PH (78.8%).
Variation in rates of SMM and MOH were 
identified between units. However, 
differences between units must be 
interpreted with caution, as they are possibly 
related to differences in the risk profile of 
pregnant women presenting to the units 
rather than the care given. Differences in 
rates of MOH between units may also reflect 
variances in practices of estimating blood 
loss.  For the first time since the inception 
of the SMM audit in 2011, no unit had an 
MOH rate statistically significantly above the 
national rate. 
However, one unit had an SMM rate (adjusted 
to exclude ICU/CCU admissions) significantly 
above the national rate (i.e. above the 99.8% 
upper limit). This unit has been notified 
in accordance with the National Office of 
Clinical Audit (NOCA) escalation process.
The perinatal mortality rate (PMR) among 
infants born to women who experienced 
SMM was 21.6 per 1,000 births, i.e. one in 45 
of the infants died. This is approximately 3.5 
times the perinatal mortality rate observed 
for all births in Ireland.
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Similar to previous years, multiple pregnancy 
was associated with an almost five times 
increased risk of morbidity. The SMM rate 
associated with multiple pregnancy was 
28.17 per 1,000 maternities compared to 
a rate of 5.76 per 1,000 maternities for 
singleton pregnancy in 2017.  
Virtually all of the women who experienced 
SMM in 2017 required an increased level of 
support/critical care. Almost half required 
Level 1 Care (44.2%), 45.5% required Level 2 
Care and 5.9% required Level 3 Care.
Only approximately one in six of the women 
admitted to an ICU/CCU required Level 3 Care 
(15.4%); over half of the women admitted to 
ICU/CCU required Level 2 Care (59.7%) and 
24.8% required Level 1 Care. This highlights 
that admission to an ICU/CCU does not infer 
that a woman has a requirement for Level 
3 Care. 
Severe maternal morbidity
• The rate of SMM was 6.42 per 1,000 maternities or one in 156 maternities.
• MOH remains the most commonly reported morbidity. 
• For the first time since the inception of the SMM audit in 2011, no maternity unit had 
an MOH rate statistically significantly above the national rate. 
• The rate of peripartum hysterectomy in 2017 was almost double the rate 
for 2012-2015.
Key findings in 2017:
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Introduction
This is the sixth report of the national clinical 
audit on severe maternal morbidity (SMM) 
in the Republic of Ireland (ROI).  SMM has 
been acknowledged internationally as an 
important quality indicator of obstetric 
care and maternal welfare, particularly in 
developed countries where maternal death 
rates are relatively low. In this context, the 
NPEC in collaboration with the NPEC Severe 
Maternal Morbidity Group has collected and 
analysed data on SMM from Irish maternity 
units since 2011. The fundamental aim of 
the audit is to provide a national review of 
clearly defined severe maternal morbidities 
(SMMs), to identify quality improvement 
initiatives and make recommendations for 
the improvement of maternal care for women 
in Ireland.   
This report provides information on the 
incidence of clearly defined SMM occurring 
in Ireland in 2017. Information on maternal 
characteristics, management of delivery and 
neonatal outcome in women experiencing 
SMM are also detailed. 
Since the inception of the SMM audit, the 
NPEC has conducted a series of topic-
specific case assessment audits on a 
triennial basis (Figure I).  These audits have 
provided additional valuable information on 
major obstetric haemorrhage (MOH) for the 
reporting years 2011-2013 and the level 
of care provided to the critically ill women 
in obstetrics for the reporting years 2014-
2016. Results of these audits have been 
reported in annual SMM reports and are 
available on the NPEC website at https://
www.ucc.ie/en/npec/npec-clinical-audits/. 
Currently, the NPEC is conducting a detailed 
case assessment on women experiencing 
Pulmonary Embolism (PE) during or up to 
42 days following the pregnancy end.  Due 
to the small incident rate in this cohort of 
women and the power of analysis, findings 
from this audit will be reported following 
completion of the audit in 2019.
Figure I: Topic-specific audits conducted by the NPEC on a triennial basis
Topic specific audits conducted by the NPEC on a triennial basis
Major Obstetric Haemorrhage
 • 2011 - 2013
Care of the Critically Ill Women in Obstetrics 
 • 2014 - 2016
Pulmonary Embolism
 • 2017 - 2019
Major Obstetric Haemorrhage
 • To be launched in 2020
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• A quantitative approach involving 
volume and weight assessment 
to estimate blood loss should be 
considered for use in all maternity 
units. Development of a national tool-
kit would assist standardisation of such 
an approach. This is being addressed by 
the National Women and Infants Health 
Programme.
• Robust clinical audit on adverse 
maternal outcomes requires the 
protected time of clinical staff. 
Funding should be provided by the 
Health Service Executive (HSE) to 
facilitate same.
• The implementation of a case 
assessment audit of major obstetric 
haemorrhage audit (MOH) is essential 
as it continues to be the leading cause 
of severe maternal morbidity.
• (a) A public health education 
programme on maternal morbidity 
and modifiable risk factors should be 
developed. 
 (b) When a pregnant woman is 
identified as high risk for significant 
morbidity, specific education should be 
available to her during antenatal birth 
preparation. A national curriculum on 
antenatal birth preparation for high 
risk pregnancies would be beneficial.
• Maternal Newborn Clinical Management 
System (MN_CMS) data from Irish 
maternity units should be collated to 
identify the influence of risk factors 
for SMM in Ireland including ethnicity, 
maternal age, body mass index (BMI), 
smoking, employment status and other 
socio-economic factors. This should 
overcome the current deficit in the 
pregnant population data. 
• Research on the incidence of morbidly 
adherent placenta in Ireland is 
warranted.
• The Ten Group Classification System 
(TGCS) is a method providing a common 
starting point for further detailed 
analysis within which all perinatal 
outcomes can be measured and 
compared. The NPEC encourages all 
units to collect TGCS data in order to 
facilitate local and national audit. 
Based on findings from this and previous reports, the NPEC Severe Maternal 
Morbidity Group makes the following recommendations:
Recommendations
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Figure II: Map of maternity units and hospital groups in the Republic of Ireland, 2017
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• Robust clinical audit on adverse maternal outcomes requires the protected time of 
clinical staff. Funding should be provided by the Health Service Executive (HSE) to 
facilitate same.
Methods
To allow for international comparison, the 
NPEC adapted the validated methodology 
of the Scottish Confidential Audit of Severe 
Maternal Morbidity (SCASMM) to evaluate 
severe maternal morbidity (SMM) in Ireland. 
This methodology utilises organ dysfunction 
criteria described by Mantel et al,1 with 
modifications used by SCASMM to include 
intervention- based criteria.2 Implemented 
nationally in 2011, this data collection tool, 
adapted for the Irish setting, has been 
endorsed by the Clinical Advisory Group at 
the Institute of Obstetrics and Gynaecology 
and the HSE National Obstetric Programme 
Working Group. 
Data recording
Since the inception of the audit in 2011, all but 
one maternity unit has contributed data for 
the years 2011, 2012, 2014 and 2015, with all 
maternity units submitting data for the years 
2013, 2016 and 2017. In 2017, there were 19 
maternity units in the Republic of Ireland. Data 
on SMM events occurring between 1 January 
and 31 December 2017 were submitted using 
a standardised notification dataset, either 
electronically via the secure online NPEC 
database or alternatively by paper format 
(See Appendix E).  The dataset is completed 
based on data on maternal and fetal 
characteristics recorded in clinical records. 
The data are subsequently processed by NPEC 
in a pseudonymised format, which means 
that they cannot be attributed to a specific 
individual without the use of additional 
information, and only the submitting unit has 
access to this information. 
Figure III illustrates the NPEC data collection 
and management processes. There has been 
a steady improvement in the overall quality 
of data reported by maternity units since the 
implementation of the NPEC SMM notification 
dataset in 2011.
1 Mantel G et al. Severe Acute maternal morbidity: a pilot study of a definition for a near-miss. BJOG 1998; 105: 985-90
2  Lennox C, Marr L. Scottish Confidential Audit of Severe Maternal Morbidity. Healthcare Improvement Scotland, 2014.
 Recommendations:
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Figure III: NPEC data collection and management processes.
Definitions and inclusion criteria  
for audit
In this audit, a case of severe maternal 
morbidity (SMM) was defined as a pregnant 
or recently-pregnant woman (i.e. up to 42 
days following the pregnancy end) who 
experienced any of the following fourteen, 
clearly defined, organ dysfunction morbidities 
in the reporting years 2013-2017: major 
obstetric haemorrhage (MOH), uterine 
rupture, eclampsia, renal or liver dysfunction, 
pulmonary oedema, acute respiratory 
dysfunction, pulmonary embolism, cardiac 
arrest, coma, cerebrovascular event, status 
epilepticus, septicaemic shock, anaesthetic 
complications, other morbidity and maternities 
involving peripartum hysterectomy. To allow 
for direct comparison with the SCASMM, two 
management proxies for maternal morbidity 
- ICU/CCU admission and interventional 
radiology - were also included. Definitions for 
all reportable SMM events are provided at the 
end of the notification form (Appendix E).
The ‘other severe morbidity’ category was 
included to explore whether further specific 
morbidities warrant inclusion in the audit. 
Findings are not provided in this report for 
cases in this category unless one of the other 
specified morbidities was also experienced.
In 2013-2017, uterine rupture was a specified 
morbidity for the audit whereas this was not 
the case in 2011, the first year of the audit. 
This change has led to a small increase in 
reportable cases of SMM. However, most 
cases of uterine rupture meet the criteria 
for major obstetric haemorrhage and were 
therefore reported in all six years of the audit.
Ten Group Classification System
In 2017, 14 of the 19 units that participated 
in the SMM audit also provided data on 
births classified according to the Ten Group 
Classification System3 (TGCS; Appendix G). The 
incidence of MOH and other SMM were classified 
according to the TGCS for these 14 units. 
Severe maternal  
morbidity event
Dataset Completed and  
Submitted to the NPEC
Data Quality Assurance  
and Management
Dissemination
Development and production 
of Annual Severe Maternal  
Morbidity Report
Severe maternal morbidity event
• Maternity unit completes NPEC Severe Maternal Morbidity Notification Dataset.
• Unit Coordinator submits data to the NPEC with possible contribution from  
 Midwives, Obstetricians and Anaesthetists.
• NPEC data manager reviews and validates all data with unit co-ordinator.  
 Data cleaning.
• Dissemination of unit specific reports to all maternity units. Dissemination of  
 the national report to various stakeholders including the Department of Health  
 and the public. 
• Data analysis and report writing.
• Review and endorsement of the report by: NPEC Severe Maternal Morbidity  
 Group, NPEC Governance Committee and the National Office of Clinical Audit.
3 Robson MS. Classification of caesarean sections. Fetal and Maternal Medicine Review. 2001;12(1):23-39.
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Rate calculations
The SMM rate is a composite rate of a group of 
clearly defined severe morbidities. In keeping 
with the internationally published literature 
in this area, the incidence rate of SMM 
and of specific morbidities are calculated 
per 1,000 maternities resulting in the live 
birth or stillbirth of a baby weighing at least 
500g. For incidence rates, 95% confidence 
intervals were calculated using the Normal 
approximation of a binomial proportion 
confidence interval.
Funnel plots are used to illustrate both 
the variation in incidence rates across 
participating maternity units and the 
deviation of the rate for each individual unit 
from the national rate. 
Denominator data on the number of 
maternities were provided by the Healthcare 
Pricing Office (HPO).4 The denominator 
underestimates the number of women at 
risk of SMM as it does not include women 
experiencing miscarriage, ectopic pregnancy 
and molar pregnancy, which may be reported 
as cases of SMM and thereby are included in 
the numerator. However, complete data on 
maternities resulting in miscarriage, ectopic 
pregnancy and molar pregnancy are not 
available and so, to ensure uniformity, the 
denominator was restricted to live births and 
stillbirths of babies weighing at least 500g. 
The approach of not including miscarriage, 
ectopic pregnancy and molar pregnancy in 
the denominator was also the approach taken 
by the SCASMM and confidential enquiries on 
maternal deaths in Ireland and the UK.5,6,7
The absence of national data on BMI, ethnicity, 
social economic status among others, means 
that the risk of SMM associated with these 
factors remains unknown. Internationally, 
social Inequalities have been shown to impact 
on risk of SMM. There is a need to establish 
the evidence in this regard in Ireland.
Rate ratios
Further analysis was conducted to assess 
variation in incidence rates between years, 
maternal age groups, and single and multiple 
pregnancies. This analysis involved using 
Poisson regression which calculates a rate 
ratio (for example, the rate in one year divided 
by the rate in the previous year). Rate ratios 
have the advantage of being easy to interpret. 
They are interpreted against the rate to which 
they are being compared to (the reference 
group/reference rate). A rate ratio is greater 
than one if a rate is greater than the rate to 
which it is being compared. For example, a rate 
ratio of 1.25 indicates the rate being examined 
is 25% higher (or 1.25 times) than the rate to 
which it is being compared. Conversely, a rate 
ratio will be less than one if a rate is less than 
the rate to which it is being compared. For 
example, a rate ratio of 0.80 indicates that the 
rate being examined is equivalent to 80% of 
the rate to which it is being compared, i.e. it 
is 20% lower. The Poisson regression analysis 
provides a 95% confidence interval for the 
rate ratio and the associated p-value, both of 
which indicate whether the rate difference 
is in line with what might be expected due 
to chance. A rate difference is considered 
to be beyond what might be expected by 
chance, i.e. statistically significant, if the 95% 
confidence interval for the rate ratio does not 
include the value one. This is equivalent to the 
p-value derived from the analysis being less 
than 0.05. If the p-value is less than 0.001 
then the rate difference may be considered 
highly statistically significant.
4 Healthcare Pricing Office. Perinatal Statistics Report 2017. (in press) Dublin: Health Service Executive. In Press
5 Lennox C, Marr L. Scottish Confidential Audit of Severe Maternal Morbidity. Healthcare Improvement Scotland, 2014.
6 O’Hare MF, Manning E, Corcoran P, Greene RA on behalf of MDE Ireland. Confidential Maternal Death Enquiry in Ireland, Report for 2013 - 
2015. Cork: MDE Ireland, December 2017.
7 Knight M, Bunch K, Tuffnell D, Jayakody H, Shakespeare J, Kotnis R, Kenyon S, Kurinczuk JJ (Eds.) on behalf of MBRRACE-UK. Saving 
Lives, Improving Mothers’ Care - Lessons learned to inform maternity care from the UK and Ireland Confidential Enquiries into Maternal 
Deaths and Morbidity 2014-16. Oxford: National Perinatal Epidemiology Unit, University of Oxford 2018
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Funnel plots
Variations in SMM between maternity units 
could potentially be due to random chance or 
reflect differences in baseline characteristics 
of the childbearing population. For this reason, 
funnel plots were used to assess performance 
outcomes for individual units in comparison 
to the overall average.8 In brief, the plot is a 
scatter diagram of individual maternity unit 
SMM rates against the number of maternities 
within that unit. The national rate is indicated 
by the solid straight line. The 95% confidence 
interval is indicated by the curved dashed 
line. The dashed lines represent the limits 
within which 95% of units are expected to 
lie (i.e. within two standard deviations). The 
99.8% confidence interval for the national 
rate is plotted using solid lines. These solid 
lines represent the limits within which 
99.8% of units are expected to lie (i.e. within 
three standard deviations). The width of the 
confidence interval is adjusted to allow for a 
meaningful comparison between unit-specific 
rates and the national rate. The confidence 
interval is wider for smaller units reflecting 
the lack of precision in rates calculated based 
on small numbers. The confidence interval 
narrows for larger maternity units, giving 
the diagram a ‘funnel’ shape. Maternity unit 
rates outside the 95% and 99.8% confidence 
interval are statistically significantly different 
from the national rate. In general, one in 20 
units would be expected to lie outside the 95% 
confidence limits by chance alone whereas 
an observation outside the 99.8% confidence 
limits is especially rare, i.e. there is a 0.2% 
chance of this happening (Figure IV).
Some of the variation in rates across maternity 
units will be due to differences in the profile 
of the women attending the maternity units. 
Data are not available to allow for adjustment 
of the profile of women attending the 
country’s maternity units. For this reason, we 
recommend a conservative interpretation of 
differences between the rates of units and 
their deviation from the national rate.
Figure IV: Diagram outlining the interpretation of a Funnel Plot 
99.8% confidence interval 
(CI). Rates above the 99.8% 
CI are markedly higher than 
the national rate.
95% confidence interval (CI).
One in 20 maternity units would be 
expected to lie outside the 95% CI by 
chance alone
National Rate
Small maternity unit Large maternity unit
8 Spiegelhalter D. Funnel plots for institutional comparison. Quality & safety in health care. 2002;11(4):390-1.
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9 Health Information and Quality Authority. Guidance on a data quality framework for health and social care 2018. : HIQA; 2018 
[cited 2019]. Available from: https://www.hiqa.ie/sites/default/files/2018-10/Guidance-for-a-data-quality-framework.pdf. 
Data Quality Statement
In the National Perinatal Epidemiology Centre 
the maintenance of data at high quality 
standards is a priority. The purpose of this 
data quality statement is to support the 
interpretation and quality of the information 
contained in this report.
This quality statement, presented in Appendix 
F, has been developed in line with the Health 
Information and Quality Authority (HIQA) 
guidance on data quality framework for health 
and social care.9 The statement describes 
the quality of the data according to five data 
quality dimensions as defined by HIQA: 
1. Relevance 
2. Accuracy and reliability
3. Timeliness and punctuality
4. Coherence and comparability
5. Accessibility and clarity
The National Clinical Audit of Severe Maternal 
Morbidity adheres to following national and 
international legislation and standards:
• The European Union General Data 
 Protection Regulation 2016
• The Data Protection Act 1988 and the 
 Data Protection (Amendment) Act 2003
• Data Protection Act 2018 (Section 36(2)) 
 (Health Research) Regulations 2018 
• Information Management Standards for 
 National Health and Social Care Data 
 (2017)
• National Office of Clinical Audit Standards 
 for National Clinical Audit
• National Standards for Safer Better 
 Healthcare (2012)
• FAIR (Findable, Accessible, Interoperable, 
 and Re-usable) Data Principles
• Internationally, social inequalities have been shown to impact on risk of SMM. There 
is a need to establish the evidence in this regard in Ireland. This requires improved 
maternity data at national level and more research in order to establish this evidence.
 Recommendation:
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In 2017, the nineteen participating maternity 
units reported that 391 women experienced 
SMM as defined in this audit. Table 1 details the 
national number of cases, total maternities and 
SMM rates derived from the participating units in 
each of the six years of the audit, 2012-2017.
From 2012 to 2017, the SMM rate varied from 
4.44 to 6.42 per 1,000 maternities or from one 
in 225 maternities to one in 156 maternities. 
The SMM rate has shown a steady increase 
since the reference year of 2012 (SMM rate 
was 4.44 per 1000 maternities), with the 
2017 rate recording a value 45% higher than 
the reference year. 
A comparable national audit in Scotland for 
the years 2003-2012, which uses the same 
composite rate for SMM as this audit, reported 
an SMM rate of 7.3 per 1,000 maternities for 
2012.10 The Irish SMM rate in 2017 (Table 1) 
was slightly below the most recent available 
Scottish rate in 2012 (rate ratio=0.89, 95% 
CI=0.78-1.02, p-value=0.094).
The increase in SMM rate mirrors a continual 
increase in the MOH rate. It may also reflect 
an improvement in case ascertainment of 
MOH.
National rate
Table 1: Incidence of severe maternal morbidity (SMM) in Ireland, 2012-2017
Note: Maternities excluding those in one non-participating unit in 2012, 2014 and 2015. CI= confidence interval. Poisson 95% confidence intervals were 
calculated for the rate and rate ratios. 
 2012 2013 2014 2015 2016 2017
Maternities in  65,768 68,047 61,593 60,006 62,871 60,910
participating units 
SMM cases 292 323 365 372 406 391
SMM rate 4.44 4.75 5.93 6.20 6.46 6.42
(95% CI) (3.92-4.96) (4.22-5.27) (5.31-6.54) (5.59-6.84) (5.85-7.12) (5.80-7.09)
Rate ratio 1.00 1.07 1.33 1.4 1.45 1.45
(95% CI) (Ref.) (0.91-1.25) (1.14-1.56) (1.2-1.63) (1.25-1.69) (1.24-1.68)
p-value 0.086 0.011 <0.001 <0.001 <0.001 <0.001
10 Lennox C, Marr L. Scottish Confidential Audit of Severe Maternal Morbidity. Healthcare Improvement Scotland, 2014.
The SMM rate is a composite rate of a group of 
clearly defined severe maternal morbidities. 
Almost three quarters of the women (n=291, 
74.4%) who experienced SMM in 2017 were 
diagnosed with one morbidity; 21% (n=81, 
20.7%) were diagnosed with two morbidities; 
3% (n=11, 2.8%) with three SMMs; and 2% 
(n=8, 2.0%) with four morbidities.
Major obstetric haemorrhage (MOH) remains 
the most commonly reported morbidity in 
almost half of the SMM audit cases in 2017 
(Table 2). The next most frequently reported 
SMM events were renal or liver dysfunction 
(12.8%), peripartum hysterectomy (PH) 
(8.4%) pulmonary embolism (PE) (6.4%), 
septicaemic shock (3.3%) and pulmonary 
oedema (3.3%).
The incidence of eclampsia in Ireland 
remains low (0.16 per 1,000 maternities) 
and compares favourably with the values 
Specific morbidities
Main Findings
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11 Schaap TP, Knight M, et al. Eclampsia, a comparison within the International Network of Obstetric Survey Systems. BJOG : an international journal of 
obstetrics and gynaecology. 2014;121(12):1521-8.
12 Vandenberghe G, Bloemenkamp K, et al. The International Network of Obstetric Survey Systems study of uterine rupture: a descriptive multi-country 
population-based study. BJOG. 2019;126(3):370-81.
13 Department of Health, Sepsis management. Guideline No 6. 2014
14 O’Hare MF, et al. on behalf of MDE Ireland. Confidential Maternal Enquiry in Ireland, Data Brief No 3. Cork: MDE Ireland, November 2018.
15 Knight M, et al. (Eds.) on behalf of MBRRACEUK. Saving Lives, Improving Mothers’ Care - Lessons learned to inform maternity care from the UK and 
Ireland Confidential Enquiries into Maternal Deaths and Morbidity 2014-16. Oxford: National Perinatal Epidemiology Unit, University of Oxford 2018. Available 
at: https://www.npeu.ox.ac.uk/mbrrace-uk
16 Lawson B, et al. UKOSS Annual Report 2017. Oxford: National Perinatal Epidemiology Unit 2017
in the UK (0.27 per 1,000 maternities) and 
Netherlands (0.54 per 1,000 maternities) for 
2014.11 When compared to European rates, 
the Irish values for uterine rupture (0.15 per 
1,000 maternities) also rank as one of the 
lowest rates across several countries (Austria 
reported the lowest prevalence among all 
the countries studied with 0.16 per 1,000 
deliveries).12
In 2017, the number and rate of cases for each 
SMM other than MOH and ICU/CCU admission 
were broadly in line with those reported 
in 2012-2016 (Table 2). An exception was 
septicaemic shock, which rate in 2017 was 
lower than the rate for 2012-2016 (although 
this was not a statistically significant 
change). Very few cases of septicaemic shock 
were reported in 2011 and 2012 but there 
were notable and successive increases in 
2013, 2014 and 2015. This may have been a 
true increase in incidence or may have been 
associated with an increased awareness and 
recognition of sepsis with the development of 
the National Sepsis Guideline.13
 
Recent reports on maternal mortality in 
Ireland and the UK have identified thrombosis/
thromboembolism as a leading direct 
obstetric cause of maternal death.14,15 At 0.41 
per 1,000 maternities or one in 2,436 women, 
the incidence of PE in 2017 was higher, though 
still in line with the rate in 2012-2016. This 
value was also higher than the reported PE 
rate in the UK (0.14 per 1,000 maternities).16 
Notwithstanding, we believe the current Irish 
rate may represent an underestimate as many 
postnatal cases will be unknown to maternity 
units as the women present to general 
hospitals: the maternity services may not be 
aware of the event. The NPEC Severe Maternal 
Morbidity Group have endeavoured to develop 
a methodology in order to capture and audit 
these cases of PE more accurately, however, 
it is proving difficult to achieve. Hospital In-
Patient Enquiry (HIPE) data are also being 
reviewed. The NPEC is undertaking a case 
assessment audit of PE in maternity units 
from 2017 to 2019 in place of the Confidential 
Audit on Critical Care in Obstetrics as part of 
its series of triennial topic specific audits.
To allow for direct comparison with findings 
from the Scottish Confidential Audit of 
Severe Maternal Morbidity (SCASMM), the 
NPEC adapted their methodology of using 
two management proxies (admission to 
ICU/CCU and Interventional Radiology) 
to identify women at high risk of severe 
morbidity. It is important to note that the 
use of Interventional Radiology (IR) is a 
procedure performed to prevent bleeding in 
women at high risk of MOH. Further, as very 
few hospitals have the resources to provide 
IR, the frequency of IR cannot be considered 
as being nationally represented. In this audit, 
the reported incidence of IR is low at 0.15 per 
1,000 maternities.
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Table 2: Incidence of specific severe maternal morbidities (SMMs) in Ireland, 2012-2017
Note: n represents the number of women affected by the specific morbidity; more than one morbidity may apply per woman % is based on the total number 
of women affected; rate is per 1,000 maternities; 95% CI=95% confidence interval; ICU=intensive care unit; CCU=coronary care unit; Uterine rupture was not 
recorded by the audit in 2011 unless associated with MOH.
2012-2016 2017
n(%) Rate(95% CI) n(%) Rate(95% CI)
Incidence of organ Dysfunction SMM
Major obstetric haemorrhage 906(56) 2.92(2.73-3.12) 191(48.8) 3.14 (2.68-3.59)
Renal or liver dysfunction 160(9.9) 0.52(0.43-0.6) 50(12.8) 0.82 (0.59-1.05)
Septicaemic shock 100(6.2) 0.32(0.26-0.39) 13(3.3) 0.21 (0.1-0.33)
Peripartum hysterectomy 106(6.5) 0.34(0.28-0.41) 33(8.4) 0.54 (0.35-0.73)
Pulmonary embolism 91(5.6) 0.29(0.23-0.35) 25(6.4) 0.41 (0.25-0.57)
Acute respiratory dysfunction 46(2.8) 0.19(0.13-0.25) 8(2) 0.13 (0.04-0.22)
Eclampsia 53(3.3) 0.17(0.12-0.22) 10(2.6) 0.16 (0.06-0.27)
Pulmonary oedema 48(3) 0.15(0.11-0.2) 13(3.3) 0.21 (0.1-0.33)
Uterine rupture 53(3.3) 0.17(0.12-0.22) 9(2.3) 0.15 (0.05-0.25)
Anaesthetic problem 18(1.1) 0.06(0.03-0.09) 4(1) 0.07 (0-0.13)
Cerebrovascular event 19(1.2) 0.06(0.03-0.09) 4(1) 0.07 (0-0.13)
Cardiac arrest 13(0.8) 0.04(0.02-0.07) 2(0.5) 0.03 (0-0.08)
Status epilepticus 6(0.4) 0.02(0-0.04) 3(0.8) 0.05 (0-0.11)
Coma 0(0) 0(0-0) 0(0) 0 (0-0)
Incidence of  SMM based on management criteria
ICU/CCU admission 774(47.8) 2.5(2.32-2.67) 149(38.1) 2.45 (2.05-2.85)
Interventional radiology 22(1.4) 0.07(0.04-0.1) 9(2.3) 0.15 (0.05-0.25)
Total women affected 1619 5.22(4.96-5.48) 391(100) 6.42 (5.77-7.07)
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Unit SMM rate National SMM rate 95% Limits 99.8% Limits
Variation in the 2017 SMM rate across the 
participating nineteen maternity units is 
illustrated in the funnel plot in Figure 1. The 
solid line represents the national SMM rate of 
6.42 per 1,000 maternities. The dashed curves 
represent the limits within which 95% of units 
are expected to lie (i.e. within two standard 
deviations). The solid curves represent the 
limits within which 99.8% of units are expected 
to lie (i.e. within three standard deviations). 
These limits are adjusted according to the 
number of maternities at each unit and are 
wider for smaller units reflecting the greater 
volatility in rates based on small numbers. 
In regards to the 95% confidence limits, we 
can expect, on average, one in twenty units 
to have a rate outside the dashed lines. 
However, differences between units must 
be interpreted with caution as they may not 
reflect care given but could reflect differences 
in levels of reporting and/or differences in the 
risk profile of the pregnant women presenting 
to the units.
Variation in rates by maternity unit
From Figure 1, it can be seen that three units 
had an SMM rate above the 95% upper limit 
and one unit had an SMM rate above the 99.8% 
upper limit. The rate for this outlying unit was 
approximately 2.25 times the national rate 
(14.74 vs. 6.42 per 1,000 maternities).
A high proportion of the SMM cases for the 
unit with the highest rate (n=11 of 24, 45.8%) 
were reported because they met the SMM 
criterion of being admitted to an ICU/CCU with 
no other SMM experienced as defined in this 
audit. Feedback from this unit identified that 
these were cases requiring monitoring above 
normal ward standard and due to low levels of 
staff in the unit, this could only be achieved 
by admission to the ICU.
It can also be seen from Figure 1 that two of 
the country’s maternity units had an SMM rate 
just below the lower 95% limit (4.28 and 3.69 
vs. 6.42 per 1,000 maternities).
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17  Lennox C, Marr L. Scottish Confidential Audit of Severe Maternal Morbidity. Healthcare Improvement Scotland, 2014.
18 Lutomski JE, Byrne BM, et al. Increasing trends in atonic postpartum haemorrhage in Ireland: an 11-year population-based 
cohort study. BJOG. 2012;119(3):306-14.en 
A total of 191 cases of MOH were reported, 
nine of these were linked to early pregnancy 
loss. Of the 182 women reporting MOH which 
was not related to early pregnancy loss, 112 
had delivery by caesarean section and 70 had 
a vaginal delivery.
The incidence of MOH was 3.14 per 1,000 
maternities in 2017. The equivalent incidence 
of MOH for the most recent year with available 
data in Scotland (2012) was 5.8 per 1,000 
maternities (95% CI=5.2-6.5), approximately 
55% higher than the Irish rate. 17
The national audit in Scotland (SCASMM) 
showed that their increasing incidence of 
SMM over a decade was due to an increase 
in the incidence of MOH. The NPEC previously 
showed that Ireland experienced an 
increasing trend in postpartum haemorrhage 
from 1999 to 2009.18
  
Figure 2 illustrates the trend in the rate of 
SMM as defined in this audit and the separate 
trends for MOH and ICU/CCU admission. An 
increasing number of MOH cases has been 
reported to this audit over the six-year period 
2011-2017 (Table 2; Figure 2).
The incidence of MOH cases increased from 
2.34 per 1,000 maternities in 2011 to 3.14 per 
1,000 maternities in 2017, an overall increase 
of 45% (rate ratio=1.45, 95% CI=1.18-1.77, 
p-value<0.001).
Major obstetric haemorrhage 
Figure 2: Trend in the rate of severe maternal morbidity (SMM), major obstetric haemorrhage 
and intensive care unit/coronary care unit (ICU/CCU) admission, 2011-2017
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Table 3: Case criteria for major obstetric haemorrhage (MOH) in 2017
Total MOH cases N=191
Met one criterion 100(52.4)
Estimated blood loss ≥ 2500ml 75(75)
Received blood products as treatment for coagulopathy 22(22)
Transfused ≥ 5 units of blood 3(3)
Met two criteria 38(19.9)
Blood loss ≥ 2500ml and received blood products  
for coagulopathy
24(63.2)
Blood loss ≥ 2500ml and transfused ≥ 5 units of blood 9(23.7)
Received blood products for coagulopathy and  
transfused ≥ 5 units of blood
5(13.2)
Met all three criteria 53(27.7)
Note: Values are shown as n (%) unless otherwise stated; Information on MOH criteria missing on one case.
Over half of the MOH cases (52.4%) recorded 
in this audit met only one of the case criteria 
for MOH (Table 3), usually the one related 
to estimated blood loss ≥ 2,500 ml. Twenty 
percent of MOH cases met two criteria and 
most of these cases involved an estimated 
blood loss exceeding 2,500ml. In a further 27% 
of MOH cases, all three criteria were met. Three 
cases met the sole criterion of receiving a blood 
transfusion of at least five units and a further 
nine women met the transfusion criteria in 
addition to experiencing a blood loss of at least 
2,500ml (Table 3). For these women, there was 
no reported receipt of coagulation factors. 
The increasing rates of MOH warrant further 
investigation. As previously mentioned, from 
2020 the NPEC will recommence the case 
assessment audit of MOH. This will enhance 
learning and identify any possible change 
in practice, risk factors or in the profile of the 
pregnant population impacting on MOH rates
• The implementation of a case assessment audit of major obstetric haemorrhage audit 
(MOH) is essential to explore the increasing rates of MOH.
 Recommendation:
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Variation in MOH rates by maternity unit





























Unit MOH rate National MOH rate 95% Limits 99.8% Limits
Figure 3 illustrates the variation in the rate of 
MOH across the country’s nineteen maternity 
units in 2017. For the first time since the 
inception of the SMM audit in 2011, no unit 
had an MOH rate statistically significantly 
above the national rate.
Figure 4: Funnel plot of the rate of major obstetric haemorrhage (MOH) in 2017 and its variation 






























Unit MOH rate National MOH rate 95% Limits 99.8% Limits
Figure 4 is identical to Figure 3 in that it 
illustrates the rate of MOH in Irish maternity 
units in 2017. However, in Figure 4 we have 
added error bars to illustrate the range of the 
annual MOH rate observed in each unit since 
2011. Considering this seven-year period, most 
of the units with over 2,000 births per annum 
had their highest or nearly highest MOH rate in 
2016. The expected greater volatility in the MOH 
rate in smaller units is evident.
Note: The error bars illustrate the variation in each unit’s annual MOH rate since 2011
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Variances in rates of MOH between units may 
reflect variances in practices of estimating 
blood loss.  Notwithstanding this issue, for the 
first time since the inception of the SMM audit 
in 2011, no unit had an MOH rate statistically 
significantly above the national rate. 
We have previously recommended that a 
quantitative approach, involving volume and 
weight assessment to estimate blood loss, 
should be considered for use in all maternity 
units and that development of a national 
tool-kit would assist standardisation of such 
an approach.19 These recommendations are 
being addressed by the National Women and 
Infant Health Programme. While no one tool 
may be completely accurate in estimating 
blood loss, a standard quantitative approach 
should facilitate a less variable assessment of 
blood loss.
• A quantitative approach involving volume and weight assessment to estimate blood 
loss should be considered for use in all maternity units. Development of a national 
tool-kit would assist standardisation of such an approach. This is being addressed by 
the National Women and Infants Health Programme.
 Recommendation:
19 Manning  E,  Leitao  S,  Corcoran  P,  McKernan  J,  de  Foubert  P,  Greene  RA,  on  behalf of the Severe Maternal Morbidity Group. 
Severe Maternal Morbidity in Ireland Annual Report 2016. Cork: National Perinatal Epidemiology Centre, 2018
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Table 4: Specific severe maternal morbidities (SMMs) in women admitted to an intensive care 
unit or coronary care unit (ICU/CCU) in Ireland, 2017
n(%)
Total women admitted to ICU/CCU 149(100)
Major obstetric haemorrhage 45(30)
Septicaemic shock 8(5.3)
Peripartum hysterectomy 8(5.3)
Renal or liver dysfunction 5(3.3)











None of the above* 70(46.7)
Note: n represents the number of women affected by the specific morbidity; % is based on the total number of women admitted 
to ICU/CCU in 2017. More than one morbidity may apply per woman; *women admitted to ICU/CCU due to other morbidities or other 
issues not listed.
The incidence of maternity admissions into an 
ICU/CCU had been increasing in early years of 
this audit, reaching its peak at 3.02 per 1,000 
maternities in 2015 (Figure 1). However, the 
rate decreased by 15% to 2.54 per 1,000 
maternities in 2016 and a further decline was 
noticed in 2017 to a rate of 2.45 per 1,000 
maternities. Table 4 details the specific SMMs 
involved in the 149 cases admitted into an 
ICU/CCU in 2017. Thirty percent of these cases 
involved MOH, 5.3% involved septicaemic shock 
and the same proportion related to peripartum 
hysterectomy. Nine cases (6%) involved acute 
respiratory dysfunction and six cases (4%) 
involved pulmonary embolism with the same 
proportion involving pulmonary oedema. 
Nearly half of the women admitted into an 
ICU/CCU in 2017 had not experienced a SMM 
as defined in this audit (“none of the above” 
46.7%, n=70 of 149). With the exception of the 
reduction noticed in 2016 (recording 34%), 
this value represents a stabilisation in the 
occurrence of this phenomenon since 2014 
(Figure 5). It must be acknowledged that 
admission to ICU/CCU in cases not meeting the 
criteria  of  SMM as defined in this audit does 
not imply inappropriate use of ICU/CCU facilities 
but suggests the requirement of a higher level 
of observation or maternal care.
These cases, requiring a higher level of 
observation (Level 1 or Level 2 Care), related 
to issues following maternal complications 
including hypertensive disorders (n=16, 
22.9%) and post-partum haemorrhage (PPH) 
with a blood loss < 2,500 mls (n=11, 15.7%). 
Pregnancy-related infection was the cause for 
ICU/CCU admission for 15.7% of women (n=11) 
and 19 (27.1%) of the admissions to these 
units related to non-obstetric complications 
(e.g. cardiac complications, diabetes, among 
other conditions). 
Admission to ICU/CCU























Figure 5: Proportion of cases admitted to ICU/CCU not experiencing a severe morbidity as 
defined in this audit, 2011-2017
The vast majority of ICU/CCU admissions with no 
other reported morbidity as defined in this audit 
occurred in small maternity units (n=40, 57.1%). 
Nearly 50% of these cases occurred in two small 
units with on-site ICU/CCU facilities but without 
obstetric high dependency facilities. Feedback 
from these units indicated that the rate of such 
ICU/CCU admissions reflected resource issues 
in cases where women required a higher level 
of monitoring. In these two units, more than half 
of the 19 ICU admissions with no other SMM as 
defined in this audit required Level 2 Care (n=12, 
63.2%). None of these 19 cases required Level 3 
Care, thus, the remaining seven cases required 
Level 1 Care (36.8%). 
The correlation between maternity units with 
a birth rate less than 2500 per annum and 
increased likelihood of level 2 care provided 
in ICU/CCU facilities was identified in the 
NPEC National Audit of Critically Ill Women in 
Obstetrics.20
20 Manning  E,  Leitao  S,  Corcoran  P,  McKernan  J,  de  Foubert  P,  Greene  RA,  on  behalf of the Severe Maternal Morbidity Group. 
Section 2 Confidential Audit of Critical Care in Obstetrics in Ireland in the Severe Maternal Morbidity in Ireland Annual Report 
2016. Cork: National Perinatal Epidemiology Centre, 2018.
Figure 6: Funnel plot of the rate of severe maternal morbidity (SMM) by maternity unit excluding 
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There were 33 reported cases of peripartum 
hysterectomy (PH) in 2017 giving a national 
PH rate of 0.54 per 1,000 maternities or 
approximately one in 1,846 maternities (Table 
2). The rate in 2017 was 58% higher than in 
2012-2016 (rate ratio=1.58, 95% CI=1.07-2.34, 
p-value=0.02). The Irish PH rate in 2017 was 
higher than PH rate reported in earlier studies 
in the United Kingdom (0.41 per 1,000 births)21 
but lower than PH rates reported in the USA and 
Australia (0.82 per 1,000 and 0.85 per 1,000 
respectively).22,23 There are no more recent 
studies in the literature for comparison with 
the Irish rate reported in this audit.  
Availability of international data on PH rates is 
limited. However, Europeristat reported rates of 
hysterectomy for postpartum haemorrhage for 
16 countries in 2010. The rates ranged from 0.1 
in Sweden to 1.3 in Estonia and the median was 
0.4 which is similar to the rate of 0.54 recorded 
in Ireland for 2017.
 
The PH rate of 0.3 for 2011-2015 increased to 
0.43 in 2016 and further increased to 0.54 in 
2017.
Of the 33 PH occurring in 2017, 69.7% (n=23) 
occurred in 2 large tertiary referral units of 
which 5 were reported in women following in-
utero transfer. A further 10 of the 33 PH cases 
were performed across 5 maternity units.
Morbidly adherent placenta (MAP) is a 
recognised risk factor for peripartum 
hysterectomy. A study conducted by the 
NPEC confirmed the established association 
between previous caesarean section (CS), MAP 
and PH.24 In this 2017 SMM audit, abnormal 
placentation, primarily MAP, was the most 
commonly reported indication for PH (26/33, 
78.8%), followed by MOH with blood loss greater 
or equal 2.5mls (6/33, 18.2%). Cervical cancer 
was the reported indication for PH for one other 
case. All of the 33 PH cases involved CS and the 
vast majority of the women had a previous CS 
(n=26, 78.8%). 
Peripartum hysterectomy
• In light of the increasing rates of peripartum hysterectomy associated with morbidly 
adherent placenta (MAP) further research on the incidence of morbidly adherent 
placenta is warranted.
 Recommendation:
21 Knight M, Kurinczuk JJ, Spark P and Brocklehurst P. United Kingdom Obstetric Surveillance System Steering Committee. 
Caesarean delivery and peripartum hysterectomy, Obstet Gynecol 2008; 111 January (1); 97-105
22 Bateman BT, Mhyre JM, Callaghan WM, Kuklina EV. Peripartum hysterectomy in the United States: nationwide 14 year 
experience. Am J Obstet Gynecol 2012;206(January (1))63 e1-8.
23 Awan N, Bennett MJ, Walters WA. Emergency peripartum hysterectomy: a 10- year review at the Royal Hospital for Women, 
Sydney. Aust N Z J Obstet Gynaecol 2011;51(June (3)):210–5. 
24 Campbell, Sarah M. et al. Peripartum hysterectomy incidence, risk factors and clinical characteristics in Ireland. Eur J Obstet 
Gynecol Reprod Biol 2016, Volume 207 , 56 - 61
The funnel plot in Figure 6 illustrates the 
variation in the SMM rate by maternity unit 
after exclusion of 70 cases admitted to an 
ICU/CCU with no other SMM experienced as 
defined in this audit. The adjusted national 
SMM rate was 5.27 per 1,000 maternities. 
The plot shows that one unit had an SMM 
rate excluding ICU/CCU admissions above the 
99.8% upper limit. This unit has been notified 
in accordance with the National Office of 
Clinical Audit (NOCA) escalation process.
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Note: Rates per 1,000 maternities. CI=95% confidence interval. Poisson 95% confidence intervals were calculated. CS=Caesarean section; *Other SMM excludes 
cases of MOH and cases of ICU/CCU admission only; Robson Group could not be determined for 12 MOH cases and 14 cases of other SMM.
Table 5: Incidence of major obstetric haemorrhage (MOH) and severe maternal morbidity (SMM) excluding MOH by 
TGCS in thirteen Irish maternity units, 2017
Group Group description Deliveries Delivered 
by CS
MOH Other SMM*
N % n Rate  
95% CI
n Rate  
95% CI
All 50435 31.9 173 3.5  (3-4.06) 118
2.39  
(1.98-2.86)











Multiparous (excluding previous 
CS), singleton, cephalic, >37/40, 
spontaneous labour




Multiparous (excluding previous CS), 
singleton, cephalic, >37/40 induced 
or elective CS
8091 14.4 18 2.22  (1.32-3.52) 10
1.24 
 (0.59-2.27)





















All women with a single pregnancy with 
a transverse or oblique lie, including 
women with previous uterine scars
176 99.4 4 22.73  (6.19-58.19) 1
5.68  
(0.14-31.66)





The Ten Group Classification System (TGCS), is 
a method providing a common starting point 
for further detailed analysis within which 
all perinatal outcomes can be measured 
and compared.25 The system classifies all 
pregnant women into one of 10 categories 
that are mutually exclusive and, as a set, 
totally comprehensive (see Appendix G).26  The 
categories are based on five basic obstetric 
characteristics that are routinely collected for 
all maternities: parity, gestational age, onset of 
labour, fetal presentation and number of fetuses.
Fourteen of the 19 maternity units that 
participated in the SMM audit also classified 
their maternities according to the Robson 
TGCS (Appendix K). The 50,435 maternities 
in these units accounted for 82.8% of the 
60,910 maternities in all 19 maternity units. 
The incidence of MOH and of “other SMM” 
(excluding cases of MOH and cases admitted 
to ICU/CCU only) in the fourteen maternity 
units that submitted TGCS data are detailed in 
Table 5. For the purpose of the TGCS analyses, 
“other SMM” refers to any of the 13 organ 
dysfunction morbidities as defined in this 
audit (excluding MOH).
Ten Group Classification System (TGCS)
25 Robson M et al. The 10-Group Classification System (Robson classification), induction of labor, and cesarean delivery. 
International Journal of Gynecology and Obstetrics 131 (2015) S23–S27 
26  Robson MS. Classification of caesarean sections. Fetal and Maternal Medicine Review. 2001;12(1):23-39.
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For the fourteen units, the MOH rate was 
3.50 per 1,000 maternities and the rate of 
other SMM was 2.397 per 1,000 maternities. 
Notwithstanding the relatively small numbers 
involved when examining by TGCS, there was 
evidence of increased risk of MOH in Group 
8 (women with multiple pregnancies) and 
in Group 9 (women with a single pregnancy 
with a transverse or oblique lie, including 
women with previous uterine scars). In what 
relates to other SMMs, there was evidence of 
increased risk of these for women in Group 
10 (all singleton, cephalic, <36/40 (including 
previous CS) as the rate for other morbidities 
was markedly higher in this group.
• The Ten Group Classification System (TGCS) is a method providing a common starting 
point for further detailed analysis within which all perinatal outcomes can be 
measurezd and compared. The NPEC encourages all units to collect TGCS data in order 
to facilitate local and national audit. 
 Recommendation:
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Previous pregnancy 
Previous early pregnancy loss was reported 
for one third of the women who experienced 
SMM in 2017 (33.3%, 130 of 384; unknown 
for seven women). Twenty two women 
(5.7%) had previously experienced three 
or more pregnancies that ended before 24 
weeks gestation.
Forty five per cent (45%) of the women 
who experienced an SMM in 2017 were 
nulliparous which is similar to previous 
years (Table 7). Women without any previous 
completed pregnancies (nulliparous) were 
over-represented in the group of individuals 
experiencing SMM, when compared with all 
the maternities in Ireland for the same year 
(45% within SMM vs 37.9% in all maternities). 
Conversely, women who had had one 
previous completed pregnancy, i.e. para 1, 
were under-represented among the SMM 
cases when compared with the population 
of women birthing in Ireland in 2017 (27.5% 
versus 34.4%). 
 Age group SMM SMM SMM SMM  All maternities 
  2014* 2015* 2016* 2017 2017** 
  (N=363) (N=371) (N=405) (N=391)  
 <20yrs 5(1.4) 3(0.8) 7(1.7) 7(1.8) 1.6% 
 20-24yrs 33(9.1) 34(9.2) 24(5.9) 39(10) 7.6% 
 <25yrs 38 (10.5) 37 (10.0) 31 (7.6) 46 (11.8) 9.2%
 25-29yrs 57(15.7) 66(17.8) 63(15.6) 57(14.6) 15.9% 
 30-34yrs 126(34.7) 117(31.5) 141(34.8) 139(35.5) 31.8% 
 35-39yrs 110(30.3) 117(31.5) 134(33.1) 108(27.6) 27.7% 
 ≥40yrs 32(8.8) 34(9.2) 36(8.9) 41(10.5) 6.2%   
Note: Values are shown as n (%) unless otherwise stated. Data for all maternities are from Perinatal Statistics Report 2017. Poisson 
95% confidence intervals were calculated for the rare ratios.* Maternal age was not known for two women in 2014, one woman in 
2015 and 2016. **Healthcare Pricing Office (HPO). Dublin: HPO, 2018. SMM rate per 1,000 births (in press). 
Table 6: Age distribution of women who experienced severe maternal morbidity (SMM), 2014-2017
Age
Maternal age, was recorded for all of the 391 
cases of severe maternal morbidity (SMM) 
in 2017 and ranged from 15 to 49 years 
(mean = 32.5 years, SD = 5.8 years). The age 
distribution of women who experienced SMM 
in 2014-2017 is detailed in Table 6. In 2017, 
63.1% were aged 30-39 years which was 
similar to the population of women who gave 
birth in 2017 (59.5%). Women aged 40 years 
or over were somewhat over-represented: 
they accounted for 10.5% of SMM cases in 
2017 compared to 6.2% of the population 
who gave birth that year. This is reflected 
in the SMM rate calculated by maternal age 
based on data for 2017 (Table 8), whereby 
the highest SMM rate was among women 
over 40 years of age. 
Maternal characteristics
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Age and Previous pregnancy 
Further in-depth analysis was carried out to study the possible effect of parity and age (and 
vice versa) and the risk of SMM.
Table 8: Rates of severe maternal morbidity (SMM) by age and parity, 2017










(Rate for age only) Adjusted for parity
<25yrs 7.74 (5.53-10.55) 1.81 (1.16-2.81) 1.73 (1.11-2.7)
25-29yrs 4.28 (3.05-5.85) (Ref.) (Ref.)
30-34yrs 6.12 (5.05-7.35) 1.43 (0.99-2.06) 1.45 (1.01-2.09)
35-39yrs 5.68 (4.58-6.97) 1.33 (0.91-1.93) 1.38 (0.94-2.01)
≥40yrs 10.33 (7.27-14.24) 2.41 (1.54-3.78) 2.42 (1.53-3.81)
Women’s Parity Unadjusted (Rate for parity only)
Parity 
(adjusted for age)
Nulliparous 7.06 (5.95-8.33) 1.44 (1.1-1.88) 1.43 (1.09-1.88)
Para 1 4.91 (3.94-6.04) (Ref.) (Ref.)
Para 2 5.28 (3.93-6.94) 1.07 (0.76-1.52) 1.06 (0.75-1.49)
Para 3+ 8.31 (5.96-11.27) 1.69 (1.17-2.45) 1.61 (1.11-2.34)
The data in table 8 indicates that parity and 
age operate as independent risk factors. The 
level of risk of SMM does not change when 
adjusted for age or parity, as the adjusted rate 
ratios remain similar to the unadjusted values 
(Table 8).
Table 7: Distribution of parity for women who experienced severe maternal morbidity (SMM), 
2014-2017
Note: Values are shown as n (%) unless otherwise stated; *Parity was not known for six, one, three and two cases in 2014, 2015, 
2016 and 2017, respectively.  ** Data for all maternities are from Perinatal Statistics Report 2017. Healthcare Pricing Office (HPO). 
















Nulliparous 152(42.3) 152(41.0) 183(45.4) 175(45) 37.9%
Para 1 101(28.1) 107(28.8) 108(26.8) 107(27.5) 34.4%
Para 2 67(18.7) 65(17.5) 73(18.1) 61(15.7) 18.3%
Para 3+ 39(10.9) 47(12.7) 39(9.7) 46(11.8) 9.4%
The above is also reflected in the SMM rate 
(Table 8), which was lowest for para 1 women 
at 4.91 per 1,000 maternities. The SMM rate 
for women who had two previous completed 
pregnancies, i.e. para 2, (5.28 per 1,000) 
was similar to the overall national rate of 
6.46 per 1,000 maternities. However, the 
SMM rate for nulliparous women was 7.06 
times higher than the overall national rate 
and approximately 44% higher than the rate 
recorded for para 1 women. Women who had 
three or more previous pregnancies, showed 
the highest SMM rate at 8.31 per 1,000 
maternities, nearly 70% higher than the rate 
for para 1 women.
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Ethnicity
There are no national data available on 
ethnicity for the pregnant population in 
Ireland which impedes the calculation of 
SMM risk per ethnic group. The distribution 
by ethnic group of the women who 
experienced SMM in 2017 broadly reflected 
that of the general population of women 
aged 15-49 years as reported from the 
most proximal national census (Table 9).27 
In those who experienced SMM there was a 
slight over-representation of women whose 
ethnicity was described as Asian as they 
made up 4.9% of SMM cases compared to 
2.7% of the population aged 15-49 years in 
this ethic group. Similarly, women of Black 
(2.8%) or Irish traveller (1.8%) ethnicity were 
over-represented in experiencing SMM when 
compared to the percentage of women aged 
15-49 years of those ethnicities in the Irish 
population.
Note: Values are shown as n (%) unless otherwise stated. *Central Statistics Office. (2018). Census 2016.
Table 9: Ethnicity of women who experienced severe maternal morbidity (SMM), 2017
SMM 2017
(n=391)
15-49 year-old female 
population, 2016*
%
White Irish 297(76) 77.1
Irish Traveller 7(1.8) 0.7
Other white background 47(12) 13.3
Asian/Asian Irish 19(4.9) 2.7
Black/Black Irish 11(2.8) 1.6
Other/mixed 3(0.8) 1.8
Not recorded 7(1.8) 2.7
27 Central Statistics Office. (2018). Census 2016.
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Table 11 details the percentage of women 
experiencing specific morbidities who were 
categorised as either overweight or obese. 
As previously mentioned, nearly 57.4% of 
women who experienced a morbidity had a 
high BMI (32.1% overweight and 25.3% obese) 
(Table 11). High BMI has been associated 
with maternal mortality and morbidity, in 
particular, morbidities such as pulmonary 
embolism, kidney disease and complications 
of anaesthetics.29,30,31,32 As shown in Table 
11, among those who had specific maternal 
morbidities, women with high BMI were 
largely over-represented in the group of those 
affected by peripartum hysterectomy, uterine 
rupture, ICU/coronary care unit admission 
and renal or liver dysfunction.
BMI category (kgm-2) SMM SMM Healthy Ireland
 2016 2017 Survey 2015
 (N=372)* (N=368)* % 
Underweight (<18.5) 7(1.9) 5(1.4) 3
Healthy (18.5-24.9) 144(38.7) 152(41.3) 44
Overweight (25.0-29.9) 135(36.3) 118(32.1) 31
Obese (≥30.0) 86(23.1) 93(25.3) 22
Note: Values are shown as n (%) unless otherwise stated. * BMI was not known for 34 women in 2016 and 23 in 2017
Table 10: Body mass index (BMI) of women who experienced severe maternal morbidity (SMM), 2017
Body mass index
Body mass index (BMI) for the women who 
experienced SMM in 2017 ranged from 17 to 
52.7 kg/m2. BMI was not known for 23 (5.9%) 
of the women. This represents a marginal 
improvement in the level of reporting of BMI 
(94.1%) when compared with SMM cases in 
2016 (91.6%).
Over 40% of the women who experienced SMM 
in 2017 had a BMI in the healthy range (41.3%), 
32.1% were overweight and 25.3% were obese 
(Table 10). In comparison to 2016 SMM data, 
this represented a noticeable increase in the 
proportion of women experiencing a SMM 
who were obese (from 23.1% in 2016 to 25.3% 
in 2017) with a reduction in women in the 
overweight category (from 36.3% in 2016 to 
32.1% in 2017).
 
It was also observed that of the total number of 
women experiencing two SMMs or four SMMs 
in 2017, a higher proportion were categorised 
as overweight or obese (56.6% of women and 
66.7% respectively).
While data on BMI is collected at unit level 
there are no national data available for the 
pregnant population in Ireland. As such the 
risk of SMM according to BMI is not possible 
to ascertain. The BMI profile in this 2017 audit 
is generally similar to that of the women in 
the 2015 Healthy Ireland Survey.28 However, 
interpretation of this comparison must 
consider the weight gain due to pregnancy 
for the women who experienced SMM as the 
Healthy Ireland Survey was of the general 
population.
28  Ipsos MRBI. Healthy Ireland Survey 2015 - Summary of Findings. Dublin: Department of Health, 2015 October. 
29 Rosenberg E, Sergienko R, Abu-Ghanem S, Wiznitzer A, Romanowsky I, Neulander EZ, Sheiner E. Nephrolithiasis during 
pregnancy: characteristics, complications, and pregnancy outcome. World journal of urology. 2011 Dec 1;29(6):743-7.
30 Knight M, UKOSS. Antenatal pulmonary embolism: risk factors, management and outcomes. BJOG 2008; 115 (4):453-461
31 Malinowski AK, Bomba-Opon D et al. Venous thromboembolism in obese pregnant women: approach to diagnosis and 
management.  Polish Gynaecology 2017; vol. 88, Issue 8: 453–459 
32 Beckett VA, Knight M, Sharpe P. The CAPS Study: incidence, management and outcomes of cardiac arrest in pregnancy in the UK: 
a prospective, descriptive study. BJOG; 2017, vol 124, Issue 9: 1374-1381
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Smoking status at the time of the first hospital 
booking appointment was known for 88.5% of 
the 391 women. Of these, 8.4% (n=29 of 346) 
were reported to have been smoking at the 
time of the first booking. The prevalence of 
smoking during pregnancy is not routinely 
published for all Irish pregnancies but rates 
of 12%, 14%, 17% and 16% have been reported 
for England, Northern Ireland, Wales and 
Scotland, respectively.33
The quantity smoked was recorded for 24 of 
the 29 women who were smokers at the time 
of the first hospital booking appointment. 
Most commonly, these women smoked 10 or 
15 cigarettes per day (range: 1-20 cigarettes/
day). Of these 24 women, six were reported 
to have given up smoking during pregnancy 
(n=6 of 24, 25%, unknown for nine cases of 
women smoking).
Alcohol drinking status at the time of the first 
hospital booking appointment was not known 
for 31.2% of the women (n=122). Of the 269 
women with available data, only 1.9% were 
reported to be drinking alcohol at first booking 
appointment (n=5).
Six women were recorded as having a 
documented history of drug abuse or 
attendance at a drug rehabilitation unit prior 
to the pregnancy (1.6%, n=6 of 384, unknown 
for seven cases). One additional woman was 
reported as using drugs during the pregnancy 
(n=1 of 384, 0.3%).
33 Euro-Peristat Project. European Perinatal Health Report. Core indicators of the health and care of pregnant women and babies in 
Europe in 2015. November 2018. Available www.europeristat.com
Smoking, alcohol and drug misuse 
*High BMI = BMI in the category overweight (25.0-29.9) and obese (≥30.0); **Lower BMI = BMI in the category underweight 
(<18.5) or healthy (18.5-24.9). 
Table 11: Proportion of women with higher Body mass index (BMI) who experienced severe 
maternal morbidity (SMM), 2017
Morbidity Women with high 
BMI*
n(%)
Women with lower 
BMI**
n(%)
Major obstetric haemorrhage 90(50) 90(50)
Peripartum hysterectomy 19(67.9) 9(32.1)
Pulmonary embolism 13(56.5) 10(43.5)
ICU/coronary care unit admission 89(63.1) 52(36.9)
Anaesthetic problems 2(66.7) 1(33.3)
Uterine rupture 6(66.7) 3(33.3)
Renal or liver dysfunction 28(62.2) 17(37.8)
• Maternal and Newborn Clinical Management System (MN_CMS) data from Irish 
maternity units should be collated to identify the influence of risk factors for SMM in 
Ireland including: ethnicity, maternal age, BMI, smoking and employment status. This 
should overcome the current deficit in the pregnant population data. 
Recommendation:
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For 10.8% of the women who experienced 
SMM in 2017, their pregnancy was the result 
of infertility treatment (n=37 of 343, 10.8%; 
unknown for 48 women). In three quarters 
of these cases the method of infertility 
treatment was in vitro fertilisation (n=22, 
75.8%). 
The prevalence of a previous caesarean 
section was over 50% among the women who 
had previously given birth (n=105 of 209, 
50.2%; not known for seven women).
Gestation at pregnancy-end for women who 
experienced a SMM ranged from five to 42 
weeks. For nearly 60 percent of the women 
affected, their pregnancy went full term (59%) 
(Table 12). For a further 25.6% of women, their 
pregnancy ended at moderate-to-late pre-
term gestation (32-36 weeks), whereas for 
3.1%, the end of pregnancy occurred before 
22 weeks gestation.
 2014 2015 2016 2017
 (N=350)* (N=367)* (N=399)* (N=386)*
Pre-viable (<22wks) 14(4.0) 20(5.4) 16(4) 12(3.1)
Extremely pre-term (22-27wks) 14(4.0) 14(3.8) 9(2.3) 11(2.8)
Very pre-term (28-31wks) 19(5.4) 25(6.8) 18(4.5) 33(8.5)
Moderate/late pre-term (32-36wks) 78(22.3) 63(17.2) 83(20.8) 99(25.6)
Term (37-41wks) 224(64.0) 241(65.7) 271(67.9) 228(59.1)
Post-term (42wks+) 1(0.3) 4(1.1) 2(0.5) 3(0.8)
Table 12: Gestation at pregnancy-end for women who experienced severe maternal morbidity, 2014-2017
Note: Values are shown as n (%) unless otherwise stated; * Gestation was not known for 15, five, seven and five cases in 2014, 2015, 2016 and 2017 respectively.
Obstetric factors associated with the severe maternal morbidity event
Early pregnancy loss (i.e. before 24 weeks 
gestation and birthweight less than 500g) 
was experienced by 12 of the 389 women 
(3.1%, unknown for two cases). These involved 
six cases of miscarriage (1.5%) and six cases 
of ectopic pregnancy (1.5%). Ten of the early 
pregnancy losses were diagnosed with 
one SMM (four miscarriage and six ectopic 
pregnancies) and two cases were diagnosed 
with two SMMs (both miscarriages). 
 
Major Obstetric Haemorrhage was the most 
frequently reported SMM associated with 
nine cases of early pregnancy loss (four 
miscarriages and five ectopic pregnancies). 
Of these nine MOH cases, one woman had an 
associated cardiac arrest and ICU admission.
 
For the remaining three cases, one was 
a complex case of septic shock requiring 
ICU admission, one met the criteria of ICU 
admission only and a further case was 
associated with an anaesthetic problem.
Severe maternal morbidity associated with early pregnancy loss
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 SMM SMM SMM SMM All SMM rate Rate ratio
 2014 2015 2016 2017 maternities (95% CI) (95% CI)
 (N=338)* (N=351)* (N=385)* (N=376)* 2017 
Single 314(92.9) 328(93.4) 356(92.5) 344(91.5) 98.2% 5.76 1.00
      (0.31-5.16) (Ref.)
Multiple 24(7.1) 23(6.6) 29(7.5) 32(8.5) 1.8% 28.17 4.89
      (4.98-19.27) (3.41-7.03)
Table 13: Single and multiple births for women who experienced severe maternal morbidity (SMM) but who did not 
experience early pregnancy loss, 2014-2017
Note: Data for all maternities are from Perinatal Statistics Report 2017. Healthcare Pricing Office (HPO). Dublin: HPO, 2018 (in press). Values are shown as 
n (%) unless otherwise stated. SMM rate per 1,000 births. *Not known for nine women in 2014, two cases in 2015, three cases in 2016 and 2017. Poisson 
95% confidence intervals were calculated for the rate ratios. Ref. = Reference group (comparison group).
A total of 376 women had an SMM which was 
not associated with early pregnancy loss 
(unknown for one case).  As shown in Table 
13, among these women, 32 had a multiple 
birth (n=32 of 376, 8.5%; single/multiple birth 
not known for one woman). Thirty-one of the 
multiple births involved twins and one involved 
triplets. In Ireland in 2017, multiple births 
made up 1.8% of all maternities (n=1,136 
of 60,908). Thus, multiple pregnancy was 
nearly five times more common in cases of 
SMM than in all maternities, a reflection of the 
increased risk of SMM associated with multiple 
pregnancy. This is evident from the national 
SMM rate of 5.76 per 1,000 maternities 
associated with singleton pregnancy in 2017 
and a nearly five times higher rate of 28.17 per 
1,000 maternities for multiple pregnancies 
(p-value<0.001). 
These findings are similar to the most 
recent reports from Scotland where 6.4% of 
SMM cases with available data in 2012 were 
associated with twin pregnancies, four times 
higher than their proportion of twin births in 
2012 (1.5%).34
Severe maternal morbidity associated with multiple pregnancy
34 Scottish Confidential Audit of Severe Maternal Morbidity: 10th Annual Report (2014). Available from:http://www.
healthcareimprovementscotland.org/our_work/reproductive,_maternal__child/programme_resources/scasmm.aspx
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The mode of delivery for over two thirds 
of the 375 (two cases unknown) women 
whose SMMs were not associated with early 
pregnancy loss in 2017 was caesarean 
section (Table 14). The majority of caesarean 
sections in cases of SMM were carried out 
prior to labour which may reflect the clinical 
complexity of the pregnancy rather than 
indicating that mode of delivery may be 
influencing the risk of SMM. Approximately 
one in three women had a vaginal delivery 
(32%), usually spontaneously (19.7% of the 
vaginal deliveries).  
  2014 2015 2016 2017
  (N=337)* (N=349)* (N=383)* (N=375)*
Vaginal 114(33.8) 124(35.5) 138(36) 120(32)
 Spontaneous 67(19.9) 73(20.9) 90(23.5) 74(19.7)
 Assisted breech - 7(2.0) 0(0) 4(1.1)
 Ventouse 25(7.4) 29(8.3) 30(7.8) 22(5.9)
 Non-rotational forceps 18(5.3) 15(4.3) 14(3.7) 19(5.1)
 Rotational forceps 4(1.2) - 4(1) 1(0.3)
Caesarean section 223(66.2) 225(64.5) 245(64) 255(68)
 Elective LSCS (no labour) 54(16.0) 63(18.1) 55(14.4) 84(22.4)
 Emergency LSCS (no labour) 99(29.4) 79(22.6) 101(26.4) 4(1.1) 
 Elective LSCS (labour) 7(2.1) 3(0.9) 7(1.8) 88(23.5)
 Emergency LSCS (labour) 61(18.1) 79(22.6) 81(21.1) 77(20.5)
 Classical 2(0.6) 1(0.3) 1(0.3) 2(0.5)
Note: Data excludes 18, 19, 18 and 14 (incl. 2 unknown) cases of early pregnancy loss in 2014, 2015, 2016 and 2017 respectively. Values shown are n (%) 
unless otherwise stated; * Mode of delivery was not known for ten cases in 2014, two cases in 2015, three cases in 2016 and two cases in 2017. For cases of 
multiple births when the mode of delivery differed for the babies, the more complex mode of delivery was taken as the primary mode. LSCS=Lower segment 
caesarean section. 
Table 14: Primary mode of delivery (excluding those who experienced early pregnancy loss) for women who 
experienced severe maternal morbidity, 2013-2017
Severe maternal morbidity associated with mode of delivery
• A public health education programme on maternal morbidity and modifiable risk 
factors should be developed.
Recommendation
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Maternal care details
The level of maternal care provided has 
been recorded since the 2014 SMM audit. 
Definitions for Level of Care is provided in 
Appendix H.
Virtually all of the women who experienced 
SMM in 2017 required an increased level 
of support/critical care (Table 15). Similar 
numbers required Level 1 and Level 2 Care 
(44.2% and 45.5% respectively). A further 
5.9% of women experiencing an SMM 
required Level 3 Care.
Approximately one in six of the women 
admitted to an ICU/CCU required Level 3 Care 
(15.4%); over half of the women admitted to 
ICU/CCU required Level 2 Care (59.7%) and 
24.8% required Level 1 Care (Table 16). This 
highlights that admission to an ICU/CCU does 
not infer that a woman has a requirement 
for Level 3 Care. As previously mentioned 
admissions to intensive care can reflect 
resource issues in cases where women 
required a higher level of monitoring in small 
maternity units without HDU facilities. Figure 
7 details the ICU and HDU facilities available 
across maternity units in Ireland. Half of the 
37 women admitted to an ICU/CCU requiring 
Level 1 Care did not experience another SMM 
as defined by this audit (n=18, 48.6%).
Table 15: Level of maternal care provided to 391 women during clinical SMM events in Ireland, 2017
Level of Care Definition N(%)
Level 0:
Normal ward care
Care of low-risk pregnant women 17(4.3)
Level 1:
Additional monitoring or 
intervention, or step down 
from a higher level of care
Patients at risk of their condition deteriorating and 
needing a higher level of observation or those recently 




Patients requiring invasive monitoring/ intervention 
including support for a single failing organ system (incl. 





support alone, or support of 
two or more organ systems
Patients requiring advanced respiratory support 
(mechanical ventilation) alone or basic respiratory 
support along with the support of at least one additional 
organ
23(5.9)
Navigation   CONTENTS     LIST OF FIGURES     LIST OF TABLES
42  Severe Maternal Morbidity in Ireland Annual Repor t 2017
Figure 7 - Map of maternity units and hospital groups in the Republic of Ireland according to the type of unit of 
care available (2017)
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Note: % shown refers to level of care per each type of morbidity; ICU=intensive care unit; CCU=coronary care unit *more than one morbidity may apply per 
woman. 











Total of women 391(100) 17(4.3) 173(44.2) 178(45.5) 23(5.9)
Major obstetric 
haemorrhage 191(48.8) 5(2.6) 99(51.8) 76(39.8) 11(5.8)
ICU/CCU 
admission 149(38.1) - 37(24.8) 89(59.7) 23(15.4)
Renal or liver 
dysfunction 50(12.8) - 31(62) 17(34) 2(4)
Septicaemic 
shock 12(3.1) - 3(25) 7(58.3) 2(16.7)
Peripartum 
hysterectomy 33(8.4) - 12(36.4) 18(54.5) 3(9.1)
Pulmonary 
embolism 25(6.4) 10(40) 8(32) 6(24) 1(4)
Uterine rupture 9(2.3) 3(33.3) 2(22.2) 4(44.4) -
Pulmonary 
oedema 13(3.3) - 4(30.8) 7(53.8) 2(15.4)
Eclampsia 10(2.6) - 4(40) 4(40) 2(20)
Interventional 




8(2) - - - 8(100)
Cerebrovascular 
event 4(1) - - 2(50) 2(50)
Status 
epilepticus 3(0.8) - 1(33.3) 2(66.7) -
Cardiac arrest 2(0.5) - - 1(50) 1(50)
Anaesthetic 
problem 4(1) - 2(50) 1(25) 1(25)
For Major Obstetric Haemorrhage, almost half 
of the cases required Level 1 Care (51.8%) 
while 39.8% required Level 2 Care and 5.8% 
required Level 3 Care. As expected clinically, 
higher levels of critical care/monitoring were 
required for the women experiencing life-
threatening maternal morbidities, e.g. acute 
respiratory dysfunction and cardiac arrest.
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Neonatal outcomes
Of the 376 women whose SMM was not 
associated with early pregnancy loss (not 
known for one woman), a total of 409 babies 
were delivered: 344 singleton births, 31 twin 
births (62 babies) and one birth of triplets. 
Information on neonatal outcome, in terms 
of perinatal death, was available for all of 
these 409 infants. Of the 409 infants, there 
were nine perinatal deaths: five stillbirths, 
four early neonatal deaths and no known late 
neonatal deaths. 
Of the nine perinatal deaths, one early 
neonatal death was associated with multiple 
pregnancy and the remaining perinatal deaths 
occurred in singleton pregnancies. Five of the 
nine perinatal deaths were born at a gestation 
between 22 and 27 weeks: two early neonatal 
death cases and three stillbirths (55.6% of all 
perinatal deaths). For one delivery (11.1%), 
a stillbirth, gestation was 28-31 weeks (very 
pre-term) and for two babies (22.2%) it was 
 
moderate/late pre-term (32-36 weeks). The 
additional early neonatal death (11.1%) was 
delivered at term (37-41 weeks). One third of 
the nine women affected by perinatal deaths 
(n=3, 33.3%) experienced major obstetric 
haemorrhage, this represents a reduction 
in this proportion when compared to 2016 
(58.8% of women experiencing perinatal death 
suffered from MOH). 
The mortality rate based on the five stillbirths 
and four early neonatal deaths among the 
409 infants was 21.6 per 1,000 births, i.e. 
approximately 2% or one in 45 of the infants 
died. This rate was 3.5 times the perinatal 
mortality rate observed for all births in Ireland 
in 2016 (p-value<0.001; Table 17). However, 
the rate is in line with the perinatal mortality 
rate among infants born to women with SMM 
in Scotland in recent years, which ranged 
from 17 to 64 per 1,000 maternities.35
Over 6% (n=25, 6.1%) of the 400 live born 
infants (with available information on 
neonatal outcome) were intubated following 
delivery in 2017 and less than half (n=189, 
46.2%) were transferred to the Special Care 
Baby Unit (SCBU) or Neonatal Intensive Care 
Unit (NICU; Table 18).
 Perinatal deaths Births PMR Rate ratio
   (95% CI)  (95% CI)
All births 2016* 374 64,133 5.8(5.3-6.5) 1.0(Ref.)
SMM 2017 9 416 21.6 (0.01, 0.04) 3.52 (1.82-6.82)
Table 17: Perinatal mortality among infants born to women with SMM in Ireland in 2017 compared to 
perinatal mortality among all infants born in Ireland
Note: PMR=perinatal mortality rate per 1,000 births; * Values refer to latest data available: Manning E, Leitao S, Corcoran P, McKernan J, de 
Foubert P, Greene RA, on behalf of the Perinatal Mortality Group. Perinatal Mortality in Ireland Annual Report 2016. Cork: National Perinatal 
Epidemiology Centre, 2017. Poisson 95% confidence intervals were calculated for the rate and the rate ratios. Ref. = Reference group 
(comparison group).
35 Lennox C, Marr L. Scottish Confidential Audit of Severe Maternal Morbidity. Healthcare Improvement Scotland, 2014.
 N=408*
Intubation following delivery 25(6.1)
Transfer to SBCU/NICU  189(46.2)
Table 18: Selected neonatal outcomes in livebirths, 2017
Note: SCBU=Special Care Baby Unit; NICU=Neonatal Intensive Care Unit.* n= total number of live births, neonatal outcome unknown 
for eight babies.
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The rate of severe maternal morbidities (SMM) in Ireland continues to increase, 
particularly the rate of major obstetric haemorrhage. This highlights the need for on-
going prospective audit in order to monitor rates of adverse maternal outcomes. Further, 
a case assessment audit of MOH is essential to identify possible change in practice, risk 
factors and population impacting on MOH.
Increasing rates of peripartum hysterectomy associated with morbidly adherent (MAP) 
placenta warrants the investigation of the incidence of MAP in Ireland.
Although SMM may reflect the complexity of the pregnant population, it also acts as a 
surrogate measure of quality of care in the maternity services. For the first time since 
the inception of the SMM audit in 2011, no unit had an MOH rate statistically significantly 
above the national rate. 
In summary
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Appendix A: Hospital co-ordinators and  
contributors 2017
Hospital Co-ordinators Additional contributors
Cavan General Hospital Dr Rukhsana Majeed Ms Karen Malocca
Coombe Women and Infants 
University Hospital Ms Julie Sloan
Dr Sharon Sheehan and  
Dr Bridgette Byrne
Cork University  
Maternity Hospital 
Ms Denise Malone Prof Richard Greene
Limerick University  
Maternity Hospial
Dr Mendinaro Imcha, Dr Alison 
DeMaio, Ms Bernie Nolan
Ms Sandra O Connor
Letterkenny General  
Hospital
Ms Mary Lynch Ms Evelyn Smith
Mayo University Hospital,  
Castlebar
Ms Diane Brady Dr Hilary Ikele
Regional Hospital, Mullingar Ms Marie Corbett
Midland Regional Hospital, 
Portlaoise
Ms Ita Kinsella 
Ms Emma Mullins
National Maternity Hospital Dr Mary Higgins
Our Lady of Lourdes Hospital, 
Drogheda
Ms Siobhan Weldon, 
Ms Sinead Dow
Dr. S O’Coigligh
Portiuncula University Hospital, 
Ballinasloe
Ms Priscilla Neilan  
Rotunda Hospital, Dublin Dr Sharon Cooley 
Sligo University Hospital Ms Madeleine Munnelly Dr Heather Langan
South Tipperary General Hospital Ms Siobhan Kavanagh
St Luke’s Hospital, Kilkenny Ms Connie McDonagh, 
Ms Fiona Dalton
University Hospital Galway Ms Louise Fitzpatrick
University Hospital Waterford Ms Janet Murphy
Wexford General Hospital Ms Helen McLoughlin
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Dr Bridgette Byrne, Consultant Obstetrician & Gynaecologist, Coombe Women & Infants University Hospital. 
Nominated by the Institute of Obstetricians & Gynaecologists, RCPI
Dr Sharon Cooley, Consultant Obstetrician & Gynaecologist, The Rotunda Hospital, 
Nominated by the Institute of Obstetricians & Gynaecologists, RCPI
Ms. Deirdre Daly, Lecturer in Midwifery, Trinity College Dublin. 
Nominated by Deputy Nursing Services Director, HSE
Ms Anne Fallon, Lecturer in the School of Nursing and Midwifery, National University of Ireland, Galway.
Dr Mary Higgins, Consultant Obstetrician & Gynaecologist, National Maternity Hospital, Holles Street, Dublin 2 
Nominated by the Institute of Obstetricians & Gynaecologists, RCPI
Ms Claire Jones, Patient Representative
Ms. Ita Kinsella, Clinical Midwife Manager 2, Midland Regional Hospital Portlaoise.
Ms. Janet Murphy, Advanced Midwife Practitioner, Waterford Regional Maternity Hospital. 
Nominated by Deputy Nursing Services Director, HSE
Dr Meabh Ni Bhuinneain, Consultant Obstetrician & Gynaecologist, Mayo General Hospital, Castlebar, Co. Mayo 
Nominated by the Institute of Obstetricians & Gynaecologists, RCPI
Dr Cliona Murphy, Consultant Obstetrician & Gynaecologist, Coombe Women & Infants University Hospital, 
Dolphins Barn, Dublin 8 
Nominated by the Institute of Obstetricians & Gynaecologists, RCPI
Prof. Richard Greene,Consultant Obstetrician/Gynaecologist, Cork University Maternity Hospital 
Chair, Director of the National Perinatal Epidemiology Centre
Ms. Edel Manning, Research Midwife, National Perinatal Epidemiology Centre, Severe Maternal Morbidity Audit Project 
Manager
Mr. Paul Corcoran PhD, Epidemiologist, National Perinatal Epidemiology Centre.
Appendix B: Maternal Morbidity Group Members
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Appendix C: NPEC Governance Committee
Chair: Dr. Michael Robson, Consultant Obstetrician and Gynaecologist, National Maternity Hospital 
Professor Tom Clarke, Consultant Neonatologist, Rotunda Hospital (Retired)
Dr Sharon Cooley, Institute of Obstetrics and Gynaecology Representative
Ms. Marie Cregan, Patient Representative, University College Cork
Professor Declan Devane, Chair of Midwifery, National University of Ireland, Galway 
Dr. Geraldine Gaffney, Senior Lecturer, National University of Ireland, Galway
Professor Richard Greene, Consultant Obstetrician & Gynaecologist, Cork University Maternity Hospital,  
Director of the National Perinatal Epidemiology Centre
Professor Shane Higgins, Master, The National Maternity Hospital
Dr. Heather Langan, Consultant Obstetrician and Gynaecologist, Sligo General Hospital 
Professor Fergal Malone, Master, The Rotunda Hospital
Professor Eleanor Molloy, Faculty of Paediatrics Representative
Ms. Connie McDonagh, Clinical Midwife Manager 3, St. Luke’s General Hospital
Dr. Mary O’Mahony, Specialist in Public Health Medicine, HSE
Dr. Sharon Sheehan, Master, Coombe Woman and Infants University Hospital
Ms Collette Tully, NOCA Executive Director, National Office of Clinical Audit
Ms Ann O’Byrne, Chair of the national Designated Midwifery Officer Group - Home Births
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Appendix D: National Office of Clinical Audit (NOCA) 
endorsement of the Severe Maternal Morbidity in 
Ireland Annual Report 2017 
 
National Office of Clinical Audit 
2nd Floor 
Ardilaun House, Block B 
111 St Stephen’s Green 
Dublin 2, D02 VN51 
Tel: + (353) 1 402 8577 
Email: auditinfo@noca.ie 
 
Professor Richard A. Greene 
Director 
National Perinatal Epidemiology Centre 
5th Floor, Cork University Maternity Hospital 
Wilton 
Cork 
               18 April 2019 
 
Severe Maternal Morbidity in Ireland, Annual Report 2017 
 
Dear Professor Greene, 
 
I acknowledge receipt of the Severe Maternal Morbidity in Ireland Report 2017 and confirm 
following circulation to the NOCA Governance Board and feedback garnered from our membership, 
we are delighted to endorse this report.  
 
The NOCA Board and Executive Team will continue to support NPEC governance efforts and in 
particular highlight the national requirement for resource commitment to ensure sustainable clinical 
audit of perinatal and maternal outcomes. 
 
You and your NPEC colleagues are to be congratulated for the quality of the report and manner in 
which you continue to engage with maternity services to maintain this work.   
 
Please accept this as formal endorsement from the NOCA Governance Board of the Severe Maternal 








Professor Conor O’ Keane FFPath FRCPI 
Chair 
National Office of Clinical Audit Governance Board 
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CONFIDENTIAL AUDIT  
OF 
  SEVERE MATERNAL MORBIDITY IN IRELAND   
 
Notification Form:  2017            
 
Hospital Name _____________________________________________________ 
 
Completed by _____________________________________________________ 
(Please print name and staff grade)                            
  
Date of clinical event: //  
Time of onset of clinical event: : 
 
Woman’s details:  
              
  Age                                                              Height at booking   ____________cm 
                                                                                                                                          BMI  
                                                                       Weight at booking ____________kg 
  Parity:         +                 
               (Status prior to delivery) 
 
Date of delivery:   //Gestation at delivery/pregnancy end     
(or pregnancy end)                                                                                                    (Completed weeks)                                                                                                                                                                                                                                                                                                     
                                            
1a. Ethnic group:    White Irish             Irish Traveller 
Any other White background       Please specify country of origin_____________________ 
Asian or Asian Irish                       Black or Black Irish 
Other, including mixed ethnic backgrounds:                    Not recorded        
1b. Was the care of this woman transferred from another hospital         Yes       No 
If yes please indicate timing of transfer in relation to pregnancy status: 
Woman transferred with fetus in-utero  Woman transferred following delivery of baby   
 
Name of referring maternity unit: _________________________________ 
Navigation   CONTENTS     LIST OF FIGURES     LIST OF TABLES
51  Severe Maternal Morbidity in Ireland Annual Repor t 2017
2 
 
2a. Did the woman smoke at booking?         Yes  please specify quantity _____________ 
No      Not recorded 
2b. Did she give up smoking during pregnancy?  Yes     No       Not recorded   N/A 
3. Did the woman drink alcohol at booking?          Yes    .No      Not recorded 
4. Is there documented history of drug abuse or attendance at a drug rehabilitation unit? 
None recorded       Prior to this pregnancy        During this pregnancy   
 
5 Obstetric history: Did the woman have a previous caesarean section      Yes       No 
6. This Pregnancy 
6 a. Was this pregnancy the result of infertility treatment? Yes    No       Unknown 
6 b. If yes please specify method of fertility treatment __________________________________ 
7. Was this an early pregnancy loss?   No Yes: MiscarriageYes: Ectopic pregnancy  
If early pregnancy loss please go to question 10 
 
8 Delivery Details 
8a. Onset of Labour:                 Spontaneous          Induced           Never in labour 
8b. Lie of fetus at delivery        Longitudinal              Oblique                   Transverse  
8c. Presentation at delivery             Cephalic             Breech                              Other  
8d. Number of fetuses/babies in this delivery   
 
9. Mode of delivery: 
 Baby 1 Baby 2*  Baby 1 Baby 2* 
i) Spontaneous vaginal  
delivery       
vi) Elective LSCS not 
in labour      
 
              
ii) Assisted vaginal   
breech delivery       
vii) Elective LSCS in 
labour      
 
              
iii) Ventouse vaginal   
delivery       
viii) Emergency LSCS 
not in labour      
 
 
iv) Non-rotational forceps  
vaginal delivery       
ix) Emergency LSCS 
in labour      
 
 
v) Rotational forceps  
vaginal delivery       
x) Classical 
Caesarean Section      
 




10. Neonatal Outcome 
Please answer yes or no as applicable  
Baby Outcomes Baby 1 Baby 2 Baby 3 
Birth weight in grams    
Intubation following delivery     
Transferred to SBCU/NICU    
*Early Neonatal Death     
*Late Neonatal Death      
Intrauterine death ≥ 500g and/or ≥ 24 weeks gestation    
 
 
11.Maternal Care Details 
11a. Location of Care during clinical event: 
Please tick all that apply 
On the ward      Delivery Suite    Theatre      High dependency unit       ICU/CCU  
11b. Level of Care Required:  
 
Please indicate the highest level of care required during the clinical event: 
 
Level of care  Definition Please tick one box 
Level 0: Normal ward care  Care of low risk pregnant women   
 
Level 1: Additional monitoring or 
intervention, or step down from 
higher level of care 
Patients at risk of their condition 
deteriorating and needing a higher level 
of observation or those recently 
relocated from higher levels of care 
 
Level 2: Single Organ Support**  Patients requiring invasive monitoring/ 
intervention* including support for a 
single failing organ system (excluding 
advanced respiratory support). 
 
Level 3: Advanced respiratory 
support alone, or support of two 
or more organ systems** 
Patients requiring advanced respiratory 
support (mechanical ventilation) alone or 
basic respiratory support along with 
support of at least one additional organ. 
 
* invasive monitoring/intervention includes the use of arterial and CVP lines  




Level 2 examples 
Basic Respiratory Support (BRS): 50% or more oxygen via face-mask to maintain oxygen saturation; Continuous Positive Airway 
Pressure (CPAP), Bi-Level Positive Airway Pressure (BIPAP) 
Basic Cardiovascular Support (BCVS): Intravenous anti-hypertensive, to control blood pressure in pre-eclampsia; Arterial line used for 
pressure monitoring or sampling; CVP line used for fluid management and CVP monitoring to guide therapy 
Advanced Cardiovascular Support (ACVS): Simultaneous use of at least two intravenous, anti-arrhythmic/anti-hypertensive/vasoactive 
drugs, one of which must be a vasoactive drug; Need to measure and treat cardiac output 
Neurological Support: Magnesium infusion to control seizures / prophylaxis of eclampsia in severe PET  
Hepatic Support: Management of acute fulminant hepatic failure, e.g. from HELLP syndrome or acute fatty liver, such that transplantation 
is being considered 
 
Level 3 examples 
Advanced Respiratory Support: Invasive mechanical ventilation 
Support of two or more organ systems: Renal support and BRS; BRS/BCVS and an additional organ supported; Intracranial pressure 
monitoring 
Reference:  Saravanakumar K, Davies L, Lewis M, Cooper GM.. High dependency care in an obstetric setting in the UK. Anaesthesia 
2008:63, 1081–6. 
 
Navigation   CONTENTS     LIST OF FIGURES     LIST OF TABLES
53  Severe Maternal Morbidity in Ireland Annual Repor t 2017
4 
 
Maternal Morbidity Category 
(See page 5 for definitions) 
Please tick all that apply 
1. Major obstetric haemorrhage (MOH)   Estimated blood loss ≥ 2500mls 
 
*please identify the criteria met for MOH in the opposite 
column accordingly. More than 1 can apply                  
Transfused with  ≥  5  units of blood 
 Received treatment for coagulopathy  
2. Uterine rupture  
3. Peripartum hysterectomy (PH) 
*please specify indication for PH in text box below  
4. Eclampsia  
5. Renal or liver dysfunction  
6. Pulmonary oedema  
7. Acute respiratory dysfunction  
8. Pulmonary embolism  
9. Cardiac arrest  
10. Coma  
11. Cerebro-vascular event  
12. Status epilepticus  
13. Septicaemic shock  
14. Anaesthetic problem  
15. ICU/CCU admission* 
*please specify indication for admission 
 
         Duration of ICU care in days/ part days 




16. Other severe morbidity, please specify   
17. Interventional radiology (IR)                                                                                                                                                                   
  

















Please notify all categories of Severe Maternal Morbidity, as 
outlined above,  occurring during pregnancy or up to 42 days 





Maternal Morbidity Definitions 
1 Major obstetric haemorrhage 
Estimated blood loss ≥ 2500ml, or transfused 5 or more units of blood 
or received treatment for coagulopathy (Fresh Frozen Plasma; 
Fibrinogen Concentrate Substitution Therapy; Platelets)   
(Also includes ectopic pregnancy meeting these criteria) 
2 Uterine rupture 
A complete separation of the wall of the pregnant uterus, with or 
without expulsion of the fetus, involving rupture of membranes at the 
site of the uterine rupture or extension into uterine muscle separate 
from any previous scar, and endangering the life of the mother or 
fetus. 
Excluded: any asymptomatic palpable or visualised defect (e.g. 
dehiscence noted incidentally at caesarean delivery) 
3 Peripartum hysterectomy Peripartum hysterectomy 
4 Eclampsia Seizure associated with antepartum, intrapartum or postpartum symptoms and signs of pre-eclampsia 
5 Renal or liver dysfunction 
Acute onset of biochemical disturbance, urea >15mmol/l, 
creatinine>400mmol/l, AST/ALT >200u/l 
6 Pulmonary oedema 
Clinically diagnosed pulmonary oedema associated with acute 
breathlessness and O2 saturation <95%, requiring O2, diuretics or 
ventilation 
7 Acute respiratory dysfunction 
Requiring intubation or ventilation for >60 minutes (not including 
duration of general anaesthetic) 
8 Pulmonary embolism 
Increased respiratory rate (>20/min), tachycardia, hypotension. 
Diagnosed as “high” probability on V/Q scan or positive spiral chest 
CT scan. Treated by heparin, thrombolysis or embolectomy 
9 Cardiac arrest No detectable major pulse 
10 Coma Including diabetic coma. Unconscious for >12 hours 
11 Cerebro-vascular event 
Stroke, cerebral/cerebellar haemorrhage or infarction, subarachnoid 
haemorrhage, dural venous sinus thrombosis 
12 Status epilepticus Constant or near constant state of having seizures that last 30mins or more 
13 Septicaemic shock 
Sepsis induced tissue hypoperfusion or hypotension persisting after 
resuscitation with 30mls/kg intravenous isotonic crystalloid fluid as 
evidenced by: 
 – Systolic blood pressure < 90 mmHg or MAP < 65 mmHg  
– Decrease in systolic blood pressure by 40mmHg from baseline 
and/or  
– Lactate > 4 mmol/l.  
14 Anaesthetic problem Aspiration, failed intubation, high spinal or epidural anaesthetic 
15 ICU/CCU admission Unit equipped to ventilate adults. Admission for one of the above problems or for any other reason. Includes CCU admissions 
16 Other severe morbidity Other severe morbidity, e.g. amniotic fluid embolism 
17 Interventional radiology Received planned (a) or unplanned (b)  interventional radiology 
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Appendix F: Data Quality Statement for the Audit on 
Severe Maternal Morbidities
Data Quality Statement 





Reference Number: NPEC-DQS-NCAoSMM-01.18 
 
Revision Number: 01 
 
Author: National Perinatal Epidemiology Centre 
 
Approved by: Richard Greene, Director, National Perinatal Epidemiology Centre 
 
Effective from: March 2019 
 









Richard A Greene, Director, 
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Data Quality Statement 





Severe Maternal Morbidity (SMM) has been acknowledged internationally as an important 
quality indicator of obstetric care and maternal welfare, particularly in developed countries 
where maternal death rates are relatively low. Further, there is evidence that commonly 
occurring life-threatening complications during or shortly after pregnancy, such as major 
obstetric haemorrhage (MOH), are under reported as they less frequently lead to death in 
high-resourced countries. In this context, the NPEC in collaboration with the NPEC Severe 
Maternal Morbidity Group, has collected and analysed data on SMM from Irish maternity units 
since 2011. The fundamental aim of the audit is to provide a national review of clearly defined 
severe maternal morbidities, to identify quality improvement initiatives and make 




2.0 Data collection for the National Clinical Audit of Severe Maternal 
Morbidity 
 
Data is collected on SMM events occurring between 1 January and 31 December each year. 
These are submitted using a standardised notification dataset, either electronically via the 
secure online NPEC database or alternatively by paper format (See Appendix E).  The dataset 
is completed based on data on maternal and fetal characteristics recorded in clinical records.  
The data are subsequently processed by NPEC in a pseudonymised format, which means that 
they cannot be attributed to a specific individual without the use of additional information, 
and only the submitting unit has access to this information.  
To allow for international comparison, the NPEC adapted the validated methodology of the 
Scottish Confidential Audit of Severe Maternal Morbidity (SCASMM) to evaluate severe 
maternal morbidity (SMM) in Ireland. This methodology utilises organ dysfunction criteria 
described by Mantel et al., with modifications used by SCASMM to include intervention- based 
criteria.  Implemented nationally in 2011, this data collection tool, adapted for the Irish 
setting, has been endorsed by the Clinical Advisory Group at the Institute of Obstetrics and 
Gynaecology and the HSE National Obstetric Programme Working Group. 
 
3.0 Dimensions of data quality for the National Clinical Audit of Severe 
Maternal Morbidity  
 
The quality of data are defined and assessed here using the internationally accepted 
dimensions recommended by HIQA: 
1. Relevance  
2. Accuracy and reliability 
3. Timeliness and punctuality 
4. Coherence and comparability 
5. Accessibility and clarity 
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Data Quality Statement 





Processes are in place to regularly monitor the relevance and use of existing data in meeting 
the needs of data users and other stakeholders.  Regular consultation with data users and 
other stakeholders is undertaken.  These are structured consultation activities focussing on 
the content and the quality of the data collected, the outcomes, continuous operational 
improvements, future direction and potential needs. 
 
 
3.2 Accuracy and reliability 
 
The population of reference is explicitly stated in all releases. Coverage rates are documented. 
Internal procedures and guidelines for data quality assessment exist and include data cleaning 
and validation procedures regarding data submitted through both the online and paper 
formats. The NPEC online database incorporates a suite of validation checks for accuracy. Data 
cleaning and correction processes are consistently applied: these include checks on the 
structure and integrity of the data, checks for missing data, checks that the data conforms to 
data source specifications and checks for outliers.  
 
 
3.3 Timeliness and punctuality 
 
The NPEC works closely with its data providers to ensure timely submission of data.  The NPEC 
makes data providers aware of submission dates, nevertheless, data collection is done  by 
staff without specific protected time for this purpose. Thus, at times, an extension of the 
submission dates may be required so as to allow submission of complete and accurate data. 
Planned releases occur within a reasonable period of time from the end of the reference 




3.4 Coherence and comparability 
 
Assessments of compliance with terminology standards are regularly undertaken to ensure 
the data collection is compliant with international and national standards, including clinical 
guidelines and current best practise. The following are applied: 
• Clinical Practice Guideline No 30 (2014). Guideline for the Critically ill Woman in 
Obstetrics : Institute of Obstetricians and Gynaecologists, Royal College of Physicians 
of Ireland and Directorate of Strategy and Clinical Programmes, Health Service 
Executive; 
• World Health Organisation, The WHO Application of ICD-10 to deaths during 
pregnancy, childbirth and the puerperium: ICD-MM 2012 France.  
• Evaluating the quality of care for severe pregnancy complications. The WHO near-miss 
approach for maternal health. World Health Organization; 2011 
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• Robson Classification: Implementation Manual. Geneva: World Health Organization; 
2017. Licence: CCBY-NC-SA3.0IGO 
• Data on management of delivery is benchmarked against national standards (IOG, 
RCPI and HSE, 2011).  
 
Divergences originating from different sources are identified and reasons are clearly and 
publically explained. For example, severe maternal morbidity and specific morbidity (e.g. 
MOH) rates are calculated differently by various countries and institutions based on the 
definition used. Updates in criteria and definitions (e.g. for case ascertainment or classification 
of specific SMMs) are also clearly explained and clarified with a transition period being applied 
to guarantee comparability.  
 
Geographic variation limitations, that impact analysis and interpretation, are documented for 
users. 
  
3.5 Accessibility and clarity 
The Annual Report for the National Clinical Audit of Severe Maternal Morbidity, its related lay 
summary and applied data collection forms are is publically available on the NPEC website: 
https://www.ucc.ie/en/npec/npec-clinical-audits/severematernalmorbidityaudit/  
Research output from the audit is catalogued according to individual staff members and 
publically available on IRIS, ResearchGate, Linkedin or other research information systems. 
Methodologies are outlined in all published outputs. 
The NPEC operates a Data Access Policy in which clear policies and procedures are outlined 
for data users in relation to the process of accessing and requesting data. 
4.0 Further information on the National Clinical Audit of Severe 
Maternal Morbidity  
Further information on the NPEC’s Severe Maternal Morbidity Audit can be found at:  
https://www.ucc.ie/en/npec/npec-clinical-audits/severematernalmorbidityaudit/  
Alternatively please contact us at: 
npec@ucc.ie 
or 
National Perinatal Epidemiology Centre,  
Dept. of Obstetrics and Gynaecology,  
5th Floor Cork University Maternity Hospital,  
Wilton,  
Cork 
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Appendix G: The Ten Group Classification System35
35  Robson Classification: Implementation Manual. Geneva: World Health Organization; 2017. Licence: CCBY-NC-SA3.0IGO.
The 10 groups of the Robson Classification 47
47 Robson Classification: Implementation Manual. Geneva: World Health Organization; 2017. Licence: CCBY-NC-SA3.0IGO.
Appendix K 
The 10 groups of the Robson Clas ification 47
47 Robson Classification: Implemen ation Manual. Geneva: World H alth Organization; 2017. Licence: CCBY-NC-SA3.0IGO.
Appendix K 
Navigation   CONTENTS     LIST OF FIGURES     LIST OF TABLES
 60
Appendix H: National Guidelines for the critically ill
woman in obstetrics36
36 Clinical Practice Guideline No 30 (2014). Guideline for the Critically ill Woman in Obstetrics : Institute of Obstetricians and Gynaecologists, Royal College of 
Physicians of Ireland and Directorate of Strategy and Clinical Programmes, Health Service Executive
Examples of Matemity Care Required at ICS Levels of Support for Critical Care (Saravanakumar et al., 2008)
Level of Care Maternity Example 
Level O: Normal ward care Care of low risk pregnant woman 
Level 1: 
Additional monitoring or intervention, 
or
step down from higher level of care
• Risk of haemorrhage
• Oxytocin infusion 
• Mild preeclampsia on oral anti-hypertensive fluid restriction etc. 
• A woman with a medical condition such as congenital heart disease, or insulin 
   dependent diabetes. 
Level 2: Single organ support Basic Respiratory Support (BRS) 
• 50% or more oxygen via face-mask to maintain oxygen saturation 
• Continuous Positive Airway Pressure (CPAP), 
    Bi-Level Positive Airway Pressure (BIPAP) 
Basic Cardiovascular Support (BCVS) 
• Intravenous anti-hypertensive, to control blood pressure in pre-eclampsia 
• Arterial line used for pressure monitoring or sampling 
• CVP line used for fluid management and 
   CVP monitoring to guide therapy 
Advanced Cardiovascular Support (ACVS) 
• Simultaneous use of at least two intravenous, anti-arrhythmic/anti- 
    hypertensive/vasoactive drugs, one of which must be a vasoactive drug 
• Need to measure and treat cardiac output
Neurological Support 
• Magnesium infusion to control seizures (not prophylaxis) 
• Hepatic support 
• Management of acute fulminant hepatic failure, e.g. from HELLP syndrome  
   or acute fatty liver, such that transplantation is being considered
Level 3: Advanced respiratory support 
alone, or support of two or more organ 
systems above
Advanced Respiratory Support
• Invasive mechanical ventilation 
Support of two or more organ systems 
• Renal support and BRS 
• BRS/BCVS and an additional organ supported 
• Intracranial ressure monitorin 
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